Next Article in Journal
Active Vibration Control of Piezoelectric Sandwich Plates
Next Article in Special Issue
Preparation of Collagen/Hydroxyapatite Composites Using the Alternate Immersion Method and Evaluation of the Cranial Bone-Forming Capability of Composites Complexed with Acidic Gelatin and b-FGF
Previous Article in Journal
Crushing Behaviors and Energy Absorption Evaluation Methods of Hexagonal Steel Tubular Columns with Triangular Cells
Previous Article in Special Issue
Evaluation of Breaking Force of Different Suture Materials Used in Dentistry: An In Vitro Mechanical Comparison
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Ceramic Nanofiber Materials for Wound Healing and Bone Regeneration: A Brief Review

by
Déborah dos Santos Gomes
1,2,*,
Rayssa de Sousa Victor
1,2,*,
Bianca Viana de Sousa
3,
Gelmires de Araújo Neves
1,
Lisiane Navarro de Lima Santana
1 and
Romualdo Rodrigues Menezes
2,*
1
Graduate Program in Materials Science and Engineering, Federal University of Campina Grande, Campina Grande 58429-900, Brazil
2
Laboratory of Materials Technology, Department of Materials Engineering, Federal University of Campina Grande, Campina Grande 58429-900, Brazil
3
Department of Chemical Engineering, Federal University of Campina Grande, Campina Grande 58429-900, Brazil
*
Authors to whom correspondence should be addressed.
Materials 2022, 15(11), 3909; https://doi.org/10.3390/ma15113909
Submission received: 6 April 2022 / Revised: 29 April 2022 / Accepted: 6 May 2022 / Published: 31 May 2022
(This article belongs to the Special Issue Naturally Derived Biomaterials for Regenerative Medicine Applications)

Abstract

:
Ceramic nanofibers have been shown to be a new horizon of research in the biomedical area, due to their differentiated morphology, nanoroughness, nanotopography, wettability, bioactivity, and chemical functionalization properties. Therefore, considering the impact caused by the use of these nanofibers, and the fact that there are still limited data available in the literature addressing the ceramic nanofiber application in regenerative medicine, this review article aims to gather the state-of-the-art research concerning these materials, for potential use as a biomaterial for wound healing and bone regeneration, and to analyze their characteristics when considering their application.

Graphical Abstract

1. Introduction

The advancement of medicine has led to an increase in the life expectation of the population, bringing with it diseases related to ageing, such as osteoporosis [1], which is the main cause of morbidity, disability, and premature death in the elderly, according to the World Health Organization [2]. Moreover, infections and bone neoplasms have increased significantly in the last decade [3]. These diseases cause severe injuries and bone problems and associated diseases account for half of the chronic diseases of the world’s population over the last 50 years [4].
Concurrently, the number of people with diabetes has increased from 108 million in 1980 to 422 million in 2014 [5], with 1.5 million deaths directly attributed to diabetes in 2019 [5]. In the US and Europe, 6.5 and 8 million people, respectively [6,7], are vulnerable to or suffer from chronic wounds, with an estimated treatment cost of over USD 25 billion [7,8,9]. Additionally, the number of people affected by chronic wounds has increased significantly in the last decade [7,9], and it is possible to estimate that, around the world, every 30 s there is a leg amputation, with 85% of them being related to foot ulcers caused by diabetes [10], reflecting the immeasurable social and economic costs that this problem causes to society.
When the subject is about the treatment of bone lesions and wounds, there is a long history about the use of autogenous, allogenic, and xenogenous materials. There is an urgent need to find reliable and more efficient materials for bone repair [4,11] and for the treatment of wounds, especially chronic ones [8,12,13], due to the health, social, and economic problems these diseases cause. These problems have led to a remarkable increase in healthcare system costs and to a reduction in the quality of life of the affected population [14,15].
An excellent alternative to such treatments has emerged through the development of regenerative medicine, which is an multidisciplinary field that aims to restore, treat, and regenerate tissues and, hence, organ functions, by creating a controlled environment that promotes and orients cell proliferation and new tissue growth [16,17]. Although it presents a simple and applicable concept, regenerative medicine presents some challenges in the reconstruction of living tissue from mature cells or stem cells, such as the control of tissue formation in culture media and the search for the development and improvement of materials that are compatible, efficient, and more accessible for tissue repair [18]. Thus, the environment chosen for neotissue growth, differentiation, and cell development is an extremely important element in this area.
In this sense, nanotechnology provides the possibility to produce surfaces, structures, and materials with nanoscale features, which can mimic the natural extracellular matrix (ECM) and favor certain functions, such as cell adhesion, cell mobility, and cell differentiation [16]. Among the possible structures that could replace the natural ECM, the great potential of nanofibers as 3D membranes/scaffolds stands out in regenerative medicine, due to the fact that nanofibers show a high surface area and a highly interconnected porous architecture, which offer a high loading capacity for biological substances and active species, facilitating the colonization of cells in the scaffold and, also, the efficient exchange of nutrients and metabolic waste between the scaffold and its environment [16,19].
In this context, ceramic nanofibers, notably those composed of bioactive glass and glass ceramics, present biological and chemical properties as well as the ability to mimic the hierarchical architecture of the ECM, depicting their great potential applications in the regeneration of bone tissue and wound healing [20,21,22,23].
Ceramic nanofibers are biodegradable and present excellent bioactivity characteristics, which favors the formation and deposition of new tissues. These fibers have advantages over several polymeric graft nanofiber materials, such as lower risks of morbidity or infection of the donor site; a high amount of reabsorption capability; ease to sterilize and store; surface nano-topographical features such as nanoroughness and micro- and mesopores that favor cell adhesion and proliferation; surface charge characteristics; and a higher number of surface-active sites. Moreover, 3D sponge/scaffolds or 2D membranes constituted by ceramic nanofibers are easily processed into various shapes and are endowed with suitable properties for the controlled release of therapeutic inorganic ions, in order to promote tissue proliferation and avoid infections; also, they exhibit a highly interconnected porous structure, with a porosity often above 90% and a high surface area, which, according to composition, present the ability to mimic the ECM of the natural bone or the skin. Based on these characteristics, ceramic nanofibers have considerable advantages over polymeric systems for bone regeneration and wound healing [24,25,26].
Moreover, applications of ceramic nanofiber were also observed in other important areas recently, such as drug and gene delivery, stem cell therapy, imaging, and diagnostics [27], which point to the versatility of these materials.
Considerable research has been conducted to explore the properties and applications of ceramic nanofibers, mainly aiming to develop ceramic nanofibrillar scaffolds. In 2006 and 2007 [28,29,30], researchers obtained nanofibrillar scaffolds of bioactive glass (BG) nanofibers and calcium phosphates (CaP), which had chemical–biological characteristics that classified them as a new generation of biomaterials. Recently, Gazquez, et al. [31] produced β-tricalcium phosphate (β-TCP) nanofiber scaffolds with approximately 100 nm in diameter, through electrospinning, offering an excellent platform for bone regeneration studies. Xiao, et al. [32] synthesized hollow mesoporous bioactive glass (MBG) nanofibers via a template-assisted sol–gel method, with an average diameter of around 40 nm. The results indicate that the nanometric diameter and the presence of the mesopores provided the excellent scaffold bioactivity, being considered a promising candidate in the controlled release of drugs and bone tissue engineering.
In the regeneration of bone tissue and wound healing, the most-used bioceramics are calcium phosphates, silica-based bioactive glasses, and glass-ceramic materials. Figure 1 displays the major biomedical applications of ceramic nanofibers.
Several methods have been developed to produce ceramic nanofibers, such as the template method, in which ceramic fibers are formed using a membrane with numerous tubular pores (5–50 mm thickness) that determines these fibers diameters [33,34]; wet spinning, which consists of pressing a syringe containing the solution through a small orifice (spinneret) into a coagulation bath containing a non-solvent, where the exchange of solvent and non-solvent leads to the thermodynamic instability of the spinning solution, inducing phase separation and precipitation of the solution into a solid fiber [35,36,37,38]; melt blowing, in which molten polymer is extruded through the orifice of a die, the fibers are formed by the elongation of the polymer streams coming out of the orifice by air-drag, and, then, they are collected on the surface of a suitable collector in the form of a web [34,39]; self-assembly, which is a technique where small components are organized in a concentrically manner through non-covalent forces (hydrophobic forces, hydrogen bonding, electrostatic reactions) into ordered and stable nanoscale supramolecular structures or patterns to form nanofibers [19]; phase-separation, in which a gel containing the material precursor solution is cooled to its gelling temperature, and, then, immersed in distilled water for solvent exchange and phase separation due to physical incompatibility. Then, the distilled water is removed and blotted with filter paper, extracting the solvent phase, while the remain phase is transferred to a freeze-drying vessel, creating the nanofiber matrix [33,34]. In the plasma method/technique, normally, a direct current pulse generates a discharge between a pair of metal electrodes in solution giving rise to plasma, which is then expanded and condensed to produce an in situ reaction and the growth of nanofibers [19,40,41,42].
However, the higher yielding methods are centrifugal jet spinning, electrospinning (ES,) and solution blow spinning (SBS). In centrifugal jet spinning, the spinning solution is placed in a rotating spinning head that is continuously fed at a certain flow rate, and, when the rotating speed reaches a critical value, the centrifugal force overcomes the surface tension of the spinning solution, resulting in the ejection of the solution [43,44,45,46,47]. The electrospinning (ES) technique is based on the generation of an electrical field between a solution placed in a capillary tube and a metal collector, and, when the electric field reaches a critical value, electrostatic repulsive forces overcome the surface tension of the polymer solution, producing a charged jet that results in the nanofibers’ formation [48,49]; and solution blow spinning (SBS), in turn, consists of a method in which the spinning solution is pumped through a matrix of concentric nozzles, where the solution passes through the inner nozzle and a pressurized air passes through the external nozzle, simultaneously, then, the high-velocity gas stream overcomes the surface tension of the solution, deforming it, and, during its journey to the collector, the nanofibers are produced by solvent evaporation [20,21,22,23].
These techniques have received great attention, recently, for the production of continuous nanoscale ceramic nanofibers [39,45,50], not only because of their high productivity, compared to the others, but also because of important advantages. ES is a simple, versatile, and efficient technique for obtaining a reproducible ceramic nanometric. SBS provides a higher productivity rate, regardless of the type of solvent, which makes possible the use of green solvents and, also, toxic organic solvents; and centrifugal jet spinning, in turn, has a low cost and high operational safety. Furthermore, nanofibers with different and complex morphology, such as a porous, hollow, or core-shell structure, can be produced with these methods [39,51], expanding the use of these ceramic nanofibers in biomedical applications. Among the materials produced by these techniques, titania, calcium phosphate, alumina, zirconia, calcium silicate, silica, and bioactive glasses can be cited [23,45,48,50,52,53,54,55,56,57].
Nowadays, ES is the most studied, and is used rote, for the successful production of several ceramic materials in 1D morphology. However, ES has some drawbacks, particularly related to low productivity, the use of high electrostatic forces to produce fine fibers, and solvents’ limitations due to the requirement of polar solvents with specific dielectric characteristics. The necessity of high voltages in the process, in the order of several tens of kilovolts, is a very sensitive issue, demanding energy consumption and potential risk.
Considering the outstanding results of studies during the last decade on the use of ceramic nanofibers in bone regeneration and wound healing, as well as the scarcity of systematic reviews on these potential applications, this review article aims to gather information about these materials and analyze their characteristics, when considering their application in regenerative medicine, with an emphasis on wound healing and bone regeneration.

2. Wound Healing

The skin is the largest organ in the body, with the functions of protecting muscles, bones, ligaments, and internal organs from external damage, whether biological, chemical, or physical (mechanical). However, its functions are affected by cuts, burns, surgical incisions, and diseases such as diabetes. After its structure is compromised, its function must be quickly restored to ensure the body’s homeostasis [8,58].
Healing usually begins, almost immediately, to avoid the risk of contamination by pathogens. However, in people who have difficulty healing, chronic wounds can be formed. In the initial stages of these wounds formation, gram-positive pathogens, such as Staphylococcus (S. aureus) and Streptococcus (S. pyogenes), are predominant, being the Gram-negative bacteria, such as Escherichia (E. coli) and Pseudomonas (P. aeruginosa), observed in the final stages [13,59], in which there tends to be an invasion of the deeper tissues of the skin. Moreover, it should be highlighted that patients with diabetes are more predisposed to infection, notably caused by S. pyogenes and S. aureus [13,60].
The body responds in different ways to fight the infection, however, when the wound becomes chronic or even acute, the use of wound dressing is necessary, once the antimicrobial action makes it possible to fight infection and stimulate cell growth [12,13]. In this sense, wound treatment dressings must have specific characteristics, such as protecting the wound from the external environment, reducing pain, removing exudate, keeping the moist environment, allowing oxygenation, gas exchange, and fluid passage, and, also, inhibiting the invasion of pathogens. Due to this, they must be preferably porous, contain antimicrobial agents, and have a 3D structure to favor cell growth and adhesion [7,58,61,62].
In this context, nanofibrous scaffolds have been gaining much attention due to outstanding characteristics, such as a high surface area, structure that favors anchoring and cell movement, surface roughness on a nanometric scale that facilitates cell interaction and adhesion, and high porosity, which allows the passage of nutrients and the output of metabolic waste [8,58,63,64]. Therefore, nanofibers are considered ideal dressing materials, as they can mimic the structure of fibrin clots and trap blood platelets in the wound, promoting the deposition, orientation, and maturity of collagen fibers, favoring hemostasis and acting as a physical barrier to avoid the pathogens’ penetration and prevent infection. Additionally, they act as an inductive template to guide skin-cell restructuring and the subsequent infiltration and integration of host tissues [65]. Furthermore, many tissues and organs are similar to highly organized, hierarchical, and nano-sized fibrous structures, which reinforces this trend in scientific research and points out that the development of nanofibrous systems is the new horizon in this technology.
Studies have observed [12,13,62] that nanofibrous membranes enable protection against pathogens and control of environmental humidity, favoring cell proliferation and the supply of molecules and bioactive ions and, also, reducing scar formation and healing time. In this context, Figure 2 exhibits, chronologically, the most relevant works that address the use of ceramic-based nanofibrous systems in wound-healing applications from the last six years.
Scaffolds made of ceramic nanofibers exhibit high porosity, high surface area, well-controlled composition, and good wettability and bioactivity [51]. Silica (SiO2) is a type of inorganic material widely used for the scaffolds preparation, due to its hydrophilic nature, physical and chemical stability, and good biocompatibility [72].
Due to this, SiO2 nanofibers has been investigated in biological applications, and relevant results have been reported. Yamaguchi, et al. [73] produced SiO2 nanofibers by ES and utilized this material as a substrate for the culture of Chinese hamster ovary cells CHO-K1 (widely used as transgenic cells for the production of substances) and a HepG2 human cell line (normally investigated as in vitro metabolic simulators). The fibers produced showed diameters in the range of 300–500 nm and porosity of 93.2%. The researchers observed a much faster growth and specific functions of hepatocytes per volume of substrates for SiO2 nanofibers culture, when compared to the values obtained in HAPS (fiber sheet composed of pulp of hydroxyapatite, a supposedly effective substrate material for CHO-K1 cell culture).
Based on these results, Das et al. [20] fabricated a bioactive nanofibrous coating of porous SiO2 as a structural matrix on an inert glass surface through the ES technique. This system proved to be non-cytotoxic and biocompatible, increasing the surface hydrophilicity and assisted cells proliferation in a short time and with a suitable adhesion for a proper fixation of the implant to the host tissue. In vitro, it acted as a structural scaffold to anchor hydroxyapatite carbonate, supporting and increasing the uniform deposition of apatite and, also, demonstrating its potential to be used as a biological coating on oral implants, when fibroblasts were used in the evaluation. Shahhosseininia, et al. [66] produced bio-inert SiO2 nanofibers, via ES followed by calcination. The nanofibers exhibited diameters between 107 to 370 and revealed a desirable growth, the attachment of L929 fibroblast cells, and, also, an adequate flattening with discrete filopodia in the nanofibrous SiO2 structure with no evidence of cytotoxicity effect.
These results corroborate the study by Garibay-Alvarado, et al. [74], who prepared electrospun silica-hydroxyapatite (SiO2-HA) ceramic membranes. The fibrillar and porous design had a diameter of 110 nm, a high percentage of viability in a fibroblast lineage, with HA stimulating cell growth and SiO2 acting as a support, allowing the cells to anchor. These materials combination improved bioactivity, and no cytotoxicity was observed. In addition, the implant area was monitored in Wistar rats, and a decrease in incision inflammation was observed six weeks after the surgical intervention, as shown in Figure 3. The sutures fell and the rat’s hair grew considerably, covering the scars and indicating the complete healing of the incisions.
Additionally, it is noteworthy that the technology for developing scaffolds/membranes for regenerative medicine has been devoted, in the last decade, to the use of therapeutic inorganic ions (TII), such as zinc (Zn), calcium (Ca), boron (B), strontium (Sr), and magnesium (Mg), which have shown excellent results in terms of anti-inflammatory and antibacterial action as well as cell multiplication stimulation [75,76]. The antimicrobial action caused by inorganic therapeutic ions is becoming more and more necessary in membranes and scaffolds, due to the increase in antibiotic resistance, proving to be a very efficient alternative against Gram negative bacteria, Gram positive bacteria, and fungi [12,77]. Figure 4 presents a schematic demonstration of the influence of the ceramic nanofibers characteristics and the importance of therapeutic ions in the wound healing process.
By loading the engineered scaffold with therapeutic agents, a dual function can be achieved: being a bed for new tissue growth; acting as a carrier for controlled in situ drug delivery; being reported for improved skin penetration, controlled release properties, and protection of drugs against light, temperature, enzymes, or pH degradation,; and stimulating of fibroblast proliferation and reducing inflammation [78,79].
It has been reported that the use of silver (Ag) nanoparticles in biomedical and wound-healing applications, due to non-toxic properties and antibacterial activity, presents the ability to inactivate a variety of Gram positive and negative bacterial strains, without influencing antimicrobial resistance pathways [80]. In this context, Ma et al. [72] prepared SiO2 nanofibers through the ES technique and grafted Ag nanoparticles onto the fiber surface through post-treatment, to be used as a reusable wound dressing. The SiO2 nanofibers had an average diameter of 260 nm, while 24 nm was the average diameter found for Ag nanoparticles. Their results showed that there was an efficient inhibition of Escherichia coli proliferation, with a long-term antibacterial effect, and this inorganic wound covering can be renewed through calcinations without losing its flexibility and antibacterial effect. It has also been shown that nanofibers have no toxicity to human cells and can promote the growth of human cells over a wide concentration range.
Electrospun SiO2 substrates modified with size-tunable Ag nanoparticles were also prepared in the work of Wan, et al. [67]. With a diameter ranging from 265–390 nm, these composite nanofibrous substrates have been demonstrated to act as a versatile surface-enhanced Raman scattering (SERS) platform that can perform the label-free detection of bio-macromolecules of bacteria, and, also, possess outstanding antibacterial activities against S.aureus and E. coli, being possible to be applied as an antibacterial dressing.
Calcium oxide (CaO) nanoparticles can be incorporated into electrospun matrices, in order to achieve improved cell viability and differentiation. Moreover, it has been reported that the possibility to replace antibiotics by the use of alternative antibacterial agents, such as CaO nanoparticles, once this material has demonstrated significant antimicrobial and antifungal activities [81]. Norris, et al. [68] incorporated CaO into a nanofibrous SiO2 scaffold produced by ES. The fibers produced with 70% of SiO2 and 30% of Ca had an average diameter of 340 nm and a surface area of 43.1 m2g−1, while the fibers with 80% of SiO2 and 20% of Ca had an average diameter of 210 nm and a surface area of 40 m2g−1. A significant increase was observed in the production of human vascular endothelial growth factor (VEGF), in a human dermal fibroblast cell line (CD-18CO) exposed to the BG samples, and, also, improved wound healing when compared to the control for both compositions.
Although BG are extensively investigated and used for wound-healing applications, the studied glass compositions have already been shown to form a layer of hydroxycarbonate of apatite (HCA) on their surface [69,82]. However, just one layer of HCA can inhibit hemostasis, and Ca deposits can impede the healing of ulcers [69,83,84,85,86]. In this context, Jung and Day [87] produced borate glass fibers scaffolds by the melt blow technique, containing one or more trace elements of Cu, F, Fe, Mn, Mo, Ni, Sr, and Zn, chemically dissolved in the material at a concentration of about 0.05 and 10% by weight. This biocompatible device has shown successful clinical results in healing diabetic foot ulcers that did not heal under conventional treatment conditions.
Also, an in vitro wound-healing assay (Figure 5) Saha, et al. [88] evidenced higher wound-healing rates than the antibacterial bioactive glass nanofibers (ABGnf) of composition 1–2 mol% of B2O3, 68–69 mol% of SiO2, ~1 × 10−3 mol% of Ag2O, and 29–30 mol% of CaO, after 24 h of testing, with 82% and 65% wound-healing rates for ABGnf, respectively, against a wound-healing rate of 47% measured for the control group. The enhanced cell proliferation observed for ABGnf in the Bo-treated group may be attributed to an increased production of tumor necrosis factor (TNF α) and interleukin-6 (IL-6) response, which, subsequently, rises VEGF production, and the increment of this growth factor—also, bFGF and their receptor proteins—accelerates endothelial cell migration, a major process of angiogenesis.
The in vitro cytotoxicity assay undertaken on human skin fibroblast cell line (SV 40-transformed GM 00637) in this study [88] evidenced a cell viability of 97% at 24 h and 95% at 72 h of ABGnf, when compared to the control, indicating that the produced ABGnf has no significant cytotoxic effect over this cell line.
A probable mechanism of the wound-healing potential of Bo containing ABGnf includes mimicking the structure of the fibrin clot, which facilitates the entrapment and aggregation of the platelets. In addition, the Ag presence provides an antibacterial potential to the wound bed, while the dissolution of the ionic products of ABGnf enhances wound healing through growth factors and collagen fiber secretion deposition [88].
Solanki et al. [69] developed a SiO2 bioactive electrospun glass scaffold, containing Na2O/CaO/K2O/CoO/MgO, reporting a sustained rate of delivery for pro-angiogenic cobalt ions, which could be mediated by the Mg content of the glass. The dissolution products stabilized HIF-1 α and induced a significantly higher expression of VEGF, suggesting that the composites activated the HIF pathway to stimulate angiogenesis.
Among the bioceramic systems to wound healing, there are, also, calcium phosphate-based materials. Hydroxyapatite (Ca10(PO4)6(OH)2, HA) is a bioceramic that can be obtained through a variety of chemical reactions, such as hydrolysis or the sol–gel method, and has been, recently, used in a variety of biomedical applications, such as drug-delivery devices and tissue-engineering scaffolds [89]. Although brittleness is one of the main problems with the use of HA, the composite fabrication is able to improve the mechanical characteristics of this material, as it is possible to highlight the use of silicate to act as a reinforcement component in flexible membranes [70].
HA has a relatively open and flexible crystal structure that can accommodate different ionic species to achieve the desired properties, a strategy that has been widely used, since this compound itself does not exhibit antimicrobial properties, is fragile, and has limited contact with host tissue [71]. In this sense, the incorporation of therapeutic metal ions to this material can promote antimicrobial activity.
As already reported in the literature, Cu2+ ions have demonstrated an interesting role in wound-healing applications, when compared to growth factors, due to its low cost, high stability, and better clinical safety, increasing angiogenic response [90,91,92]. Moreover, it has already been observed [93,94,95] that Cu2+ can stimulate the expression of pro-angiogenic factors, such as growth factor-β (TGF-β) and VEGF, in wounds created in diabetic mice.
Zhao, et al. [96] produced electrospun dressings of bioactive borate glass fibers (6Na2O, 8K2O, 8MgO, 22CaO, 54B2O3, 2P2O5; mol%) doped with CuO (0–3%). Fibers exhibited diameters ranging from 0.4–1.2 μm and, after immersion in SBF, induced the HA layer formation in nearly seven days. Cellular tests showed non-toxicity to human umbilical vein endothelial cells (HUVECs) and fibroblasts, promoting HUVEC migration, tubule formation, and vascular endothelial growth factor (VEGF) secretion. Moreover, at 7 and 14 days post-surgery, fibers doped with 3% Cu showed a significantly better ability to stimulate the expression of HUVEC genes related to fibroblast angiogenesis, when compared to undoped fibers and untreated defects (control).
Table 1 summarizes the main characteristics about ceramic nanofibers with promising application for wound healing, showing information about their most relevant biological properties according to the group of ceramic nanofibers mentioned throughout the manuscript.

3. Bone Regeneration

The number of diseases and bone fractures has been growing worldwide, due to ageing and an increase in population weight problems, such as obesity [97]. Due to this, bone injuries, notably “critical defects” (which are large bone defects that are not able to regenerate on their own [4]), whether resulting from trauma, infections, or tumors, have become a complex challenge for current orthopedics [97], bringing great losses to health and life quality.
In this scenario, it is estimated that there are more than 4 million bone tissue transplantations annually, the second-most performed in the world [3,98]. While autogenous bone grafting is still considered the “gold standard” for repairing bone defects [4,98], however, its disadvantages includes secondary damages such as high morbidity at the donor site, infections, pain, shape and size limitations, and insufficiency of autogenous bone, among others [4,98].
This awakens the need of search for alternative materials for bone transplantation and reconstruction purposes, standing out the development of 3D scaffolds systems for bone tissue engineering, which are biocompatible, biodegradable, and favor cell adhesion and proliferation. In this sense, scaffolds made of ceramic nanofibers displays interesting characteristics, such as nanorugosity, nanotopography, wettability, bioactivity, and ECM-like morphology, which favor cell multiplication and have shown promising results for the repair and rebuild of damaged bones, including critical defects [99,100].
Ceramic materials used for bone regeneration purposes are known as bioceramics, which can be classified as bioinert, bioactive, or bioresorbable, and display effective properties for the use in scaffolds. Bioinerts maintain their physical and mechanical properties after implantation, exhibiting minimal interaction with the surrounding tissue, high chemical stability, and mechanical resistance, with alumina and zirconia being the most common materials in this subcategory [101]. Bioactive ceramics have the ability to settle on the surface of the implant, allowing a deep interaction and chemical bond with living bone tissue, without the intervention of the fibrous tissue layer. Bioresorbable ceramics, in turn, are gradually degraded or absorbed in vivo, replacing the damage site with the new tissue formed.
Several ceramic materials have been used in scaffolds for bone regeneration purposes, being able to increase cell proliferation and/or with antibacterial action and/or aiming to increase resistance in hybrid systems, such as: CaP [98,102], MgO [103,104], BG [98,105], calcium silicates (CaSi) [3,106], Mg2SiO4 (fosterite) [107], TiO2 and Na2Ti6O13 [108,109], perovskite ceramics [110], γ-Fe2O3 and Fe3O4 [111,112], etc. Among these, CaP, BG, and CaSi stand out as the most commonly bioactive and bioresorbable ceramics for applications in bone regenerations [113].
On the other hand, recent studies have shown that bioceramic nanofibers exhibit an outstanding performance, when compared to powdery or micrometric 1D materials for the use in bone tissue regeneration. In this context, Figure 6 covers, chronologically, the most relevant works that address the use of ceramic-based nanofibrous systems in bone regeneration applications over the last six years.
The literature indicates an association between the inherent characteristics of the nanometric character of the nanofibers bioceramics microstructure (fiber topography, arrangement/disposition of nanofibers, pore sizes and distribution, etc.) and the chemical-biological properties of these materials, generally with a synergism between them, which implies the extremely satisfactory performance in cell adhesion, proliferation, and differentiation in the in vitro and in vivo assays of the nanofibrous scaffolds [28,55,122,123,124,125,126,127,128].
CaP-based bioceramics, such as HA, β-TCP, Ca3(PO4)2, and biphasic calcium phosphate (BCP), a mixture of HA and β -TCP composed of the same ions as bone, are inorganic materials that show excellent biocompatibility and have received great attention for bone repair applications, due to their chemical and structural similarities with the inorganic phase of human bone. They have also been shown to be efficient bone substitutes that respond well to material resorption/bone replacement events, being widely used in the hard tissue replacement area, as well as being used in various biomedical applications aiming at bone regeneration [129]. Among them, β-TCP and HA are the most used materials for bone regeneration, since they have a similar composition to the inorganic constituents of bone, allowing the production of apatite, the main inorganic bone component. When compared to β-TCP, HA is slowly reabsorbed and undergoes a little conversion to a bone-like material after implantation. However, β-TCP scaffolds generally exhibit lower strength than HA scaffolds with the same porosity, which makes their use in bone repair challenging [130,131,132,133].
Holopainen and Ritala [122] produced HA fibers through the ES technique, followed by annealing (electroblowing), and observed that fibrous membranes had fiber mean diameters ranging from 200 ± 70 to 330 ± 140 nm, depending on the solution characteristics and the experimental parameters used. The relative humidity (RH) chosen for spinning was an important factor for the fiber properties, with it being noticed that a RH greater than 25% promotes an increase in the amount of wet droplets that reaches the collector, hampering the collection of continuous fibers, while smaller RH values, generally, induce the formation of smoother and larger diameter fibers. In spinning techniques like this, as well as in ES and SBS, the RH is a parameter that is difficult to control, once it is related to the climatic characteristics of the environment where the spinning takes place. It was also shown that randomly oriented HA fibers induce the fast formation of a homogeneously apatite layer around the fibers after a 6 h immersion in simulated body fluid (SBF), being considered a high bioactivity material. In the same year, Yi, et al. [134] developed porous HA fibers loaded with bovine serum albumin (BSA) that exhibited good drug-controlling release properties, observing that, after three days of immersion in phosphate buffered saline solution (PBS), there was an abundant formation of nano-bone apatite on almost all surfaces of the glass fibers.
The β-TCP has also shown excellent performance as a scaffold for bone regeneration, promoting osteogenic induction and biosorption [135,136,137]. Gazquez et al. [31] presented the first report of fabrication of β-TCP fibrous scaffolding using ES. The fibers showed small diameters, in the range of 100–125 nm, after calcination at 950 °C and unidirectional grain growth during the sintering phase, with the smallest grain size ever produced. They noticed that fast heating/cooling and short sintering times help to keep small grain sizes, producing a three-dimensional material that can provide an excellent platform for bone regeneration studies. Calcination temperatures were also analyzed by Oliveira et al. [56] in the production of biphasic HA and β-TCP submicron fibers, using the SBS spinning technique. Fibers were calcinated at 900 and 1000 °C, proving to be non-cytotoxic, presenting inhibitory concentration (IC) > IC50, and, also, exhibiting a formation of acicular apatite layers after immersion in SBF.
However, CaP nanofibers are brittle and need to be used in combination with some reinforcement component for load-bearing applications. In this sense, Garibay-Alvarado et al. [74] studied the effect of the SiO2 and HA combination through the production of coaxial composite nanofibrous membranes of SiO2-HA by the ES technique. The obtained blanket showed a nanofibrous characteristic with an average diameter of 110 ± 17 nm after heat treatment at 800 °C, surface area of 6.57 m2/g, and a pore size of 15.75 nm. It was possible to observe that the combination of SiO2 and HA significantly improves bioactivity, when compared to pure SiO2 and HA membranes. In addition, the fibrous and porous design demonstrated a high percentage of viability in a fibroblast cell line, with greater cell viability for the SiO2-HA compound, which may be related to the HA ability to stimulate cell growth [138] and the SiO2 ability to provide support for cell anchoring [139]. On the other hand, according to the literature, the fibrous architecture helps to maintain a normal phenotype of cells, which plays a fundamental role in the regulation of cell behaviors, such as cell adhesion, cell viability, and proliferation [140].
BG are biocompatible, bioactive, and osteoconductive materials that have been commonly used for bone tissue regeneration [141]. The bioactive capacity of these glasses in bone regeneration applications is directly related to the biological capacity of forming an active layer of HCA, once in contact with biological fluids [142,143,144]. Many studies shows that BG promotes enzymatic activity [145,146] and vascularization [147,148], as well as maintains osteoblastic adhesion, in addition to regulating the growth and differentiation of mensenchymal cells into osteoblasts [149], while, also, exhibiting excellent biocompatibility properties, as observed in in vivo studies [28,150].
Luo et al. [55] fabricated nanofibrous 3D binary bioactive glass scaffolds (SiO2–CaO) by combining the template-assisted sol–gel technique and using bacterial cellulose as a calcination model. The study confirmed that the Ca/Si molar ratio and the nanofibers diameter can be controlled by the immersion time in the solution of tetraethyl orthosilicate and ethanol. The best results were obtained for the scaffold constituted of 60 a.% of Si and 40 a.% Ca (after 6 h of immersion), which exhibited a nanofiber diameter smaller than 29 nm, with a highly porous structure and a surface area of 240.9 m2g−1. As shown in Figure 7, cell differentiation was analyzed by an immunofluorescence-staining assay against a blank control, showing that the binary scaffold induces cell differentiation during five days of culture, with no dead cells being observed. Furthermore, Thiazolyl Blue Tetrazolium Blue (MTT) analysis indicated that cells are viable and proliferate well, as well as that cell viability was significantly higher in the BG scaffold when compared to the control. The excellent biocompatibility, better cell proliferation, and high alkaline phosphatase (ALP) activity may result from the combination of nanotopological surface characteristics, macro and mesoporous structure, large surface area, and 3D biomimetic architecture, in addition to the chemical structure that promotes better cell adhesion and Si4+ and Ca2+ release, which can accelerate osteoblast proliferation and differentiation [151,152,153].
Luo, et al. [154] produced a nanofibrous bioactive glass scaffold via a sol–gel route, using a 3D bacterial cellulose aerogel as a template, followed by calcination. Nanofibers exhibited diameters nearly 16 nm, with an interconnected porous structure that proved to be highly bioactive. Moreover, in another study, Luo, et al. [155] found similar results for 58S BG scaffolds produced using bacterial cellulose (BC) as a template, which also exhibited bioactivity and biocompatibility with mouse primary osteoblastic cells, as indicated in in vitro cellular studies. Wen, et al. [156] first reported the use of amino-modified BC as template to prepare a 3D nanofibrous BG scaffold, via a modified sol–gel under ultrasonic treatment. Results indicated that the amino groups in the BC template can effectively promote the absorption of the CaO and SiO2 deposited through their precursors, promoting the successful formation of the nanofibrous BG scaffold after calcination at 700 °C. The obtained scaffold exhibited an average nanofiber diameter of 20 nm and an interconnected porous structure (Figure 8A). The SBF immersion test showed a deposition of HA on the scaffold surface with an HA morphology varying from a needle-like structure to a flower-shaped structure after immersion times between one and seven days, as shown in Figure 8. The researchers suggested that the rapid formation of HA may be related to the solubility of the nanofibers in SBF solution, which promotes the release of large amounts of Ca2+ ions during the initial immersion stage and increases the relative saturation of HA. Xiao et al. [32] also produced hollow mesoporous bioactive glass (MBG) nanofibers via a template-assisted sol–gel method, which exhibited diameters of around 40 nm, with a large specific surface area of 579.0 m2g−1 and outstanding bioactivity.
A BG nanofibrous scaffold bioactivity was also studied by Medeiros et al. [23]. In this study, 3D nanofibrous scaffolds of 68S and 63S BG were fabricated by SBS in a one-step process. After calcination at 800 °C, the fibers showed cylindrical morphology with an average diameter in the range of 344 to 358 nm. The high bioactivity in SBF was evidenced with the formation of HA crystals after 12 h of immersion. The MTT assay showed an increase in cell uptake after the culture time, promoting high cell proliferation (Figure 9A). Protein analysis also showed a significant increase in the amount of protein over time (Figure 9B). ALP activity increased after the culture time, exhibiting ALP differentiation levels consistent with cytocompatibility. The scaffolds with the highest presence of Ca showed higher ALP at 14 days, which may indicate that higher Ca dissolution rates induce the proliferation and differentiation of osteoblastic cells (Figure 9C). The smallest amount of Ca ion, in turn, delayed the ALP development, reaching the maximum value after 21 days.
Ceramics based on CaSi, such as wollastonite (CaSiO3, CS), larnite (β-Ca2SiO4), and α-calcium disilicate (Ca2SiO4), in turn, have shown high biocompatibility and mechanical strength and, also, demonstrate excellent bioactivity and a higher degradation rate than CaP ceramics [3]. The degradation of CaSi releases Si and Ca ions, which promote cell proliferation [114,157]. Furthermore, it is observed that CaSi cements induce in vivo bone formation [158,159], acting as a basis for cell adhesion and promoting cell proliferation and bone tissue growth.
Studies [160,161,162,163] have shown that the chemical components released by CS can stimulate osteogenic proliferation and the differentiation of bone marrow stem cells (BMSCs) and osteoblasts, in addition to exhibiting faster bone regeneration capacity and inducing better angiogenesis when compared to traditional CaP bioceramics.
Lin, et al. [164] produced bioceramics constituted by CS nanofibers, with a hydrothermal synthesis route and calcination step at 800 °C. The nanofibers exhibited a fiber a diameter between 10–30 nm and a high flexural strength by pressureless sintering. The flexural strength test showed that the CS bioceramics reached an upper limit value similar to that of human cortical bone (145.70 ± 2.74 MPa). Bioceramics composed by nanostructured materials can present high densification when compared to micro-sized powders [165], which could explain the high strength obtained by the authors. On the other hand, the bioactivity performed by SBF immersion indicates that this material induces the fast deposition of the apatite layers, which plays an important role in bone bonding between the bioactive material and the host tissue [166,167,168]. These results corroborate with the in vivo experimental results presented in the literature, suggesting the potential application of these CS bioceramics as filler materials for bone implants [160,161,169].
More recently, Du, et al. [170] produced CS nanofibers with a core-shell structure, via ES and calcination at 800 °C, 1000 °C, and 1200 °C. Nanofibers calcined at 800 °C presented a higher porous-like structure than fibers fired at 1000 °C and 1200 °C, after 21 days of immersion in deionized water at 37 °C. This may be related to the calcination temperature of the sample, which promotes a faster degradation rate for the sample calcined at 800 °C, as can be seen in Figure 10. The nanofibers showed a faster degradation rate in the core (CaSiO3), when compared to the shell (SiO2), notably the 1000 °C and 1200 °C fired fibers, which allows, according to the authors, their application as a nanotube drug carrier to provide the controlled release of bioactive ions. In order to investigate the influence of calcination temperature on the microporous characteristics of CS fibers and their ability to induce bone regeneration, Du et al. [128] produced CS nanofibers via ES with sintering at 800 °C, 1000 °C, and 1200 °C. They observed that the rise in temperature promoted greater crystallinity and a lower degradation rate, and that nanofibers calcined at 1000 °C exhibited the better release profile for osteogenic differentiation and the proliferation of mesenchymal bone marrow stromal cells.
Many types of nanofibrous composites have been produced, with the aim of mimicking the natural extracellular bone tissue matrix [115,171,172,173,174]. In recent years, hybridized carbon nanofibers (CNFs) containing inorganic nanoparticles have been reported as materials with great potential for bone tissue repair [54,175]. When compared to organic–inorganic nanofibers, CNF hybrids have distinguished characteristics for bone repair, as they favor the fixation and proliferation of bone cells, such as osteoblasts and bone mesenchymal stromal cells (BMSCs). Moreover, when obtained by heat treatment of the polymer precursor at temperatures below 1000 °C, they integrate into tissues and can undergo a slow oxidation in the biological environment, becoming non-toxic organic forms for the body [176]. In addition, the physical–chemical modification through the incorporation of osteoinductive bioceramic nanoparticles makes the CNF hybrids more flexible and osteocompatible [54].
BG nanoparticles have been used to produce hybridized CNFs, due to their well-known high bioactivity and osteoinductivity. Cheng et al. [54] prepared hybrid CNF/BG nanofibers through ES with different molar ratios between Ca/P, in order to regulate their chemical structures and biological properties. The hybrid nanofibers had an average diameter ranging from 220–320 nm and were capable of inducing the nucleation and growth of apatite with the dissolution of BG nanoparticles. Cheng et al. also observed that scaffolds composed of BG (Ca/P = 1.0) exhibited the fastest proliferation rate and the highest expression of alkaline phosphatase activity. Such results support the theory that cells tend to preferentially adhere to rough surfaces rather than smooth surfaces, promoting better cell proliferation by absorbing bioactive components from the culture medium [116,177,178].
Smolka, et al. [179] noticed that carbon nanofibers containing silicon and Ca compounds exhibited higher HA deposition, after three days of immersion in SBF, when compared to unmodified carbon nanofibers. The nanofibers produced by ES showed a porosity between 0.47 and 0.76 and an average diameter around 190 nm. The carbon nanofibers containing Si and Ca in contact with osteoblast cells were biocompatible and exhibited lower levels of cytotoxicity when compared to the control, and, also, showed higher ALP activity. Waisi, et al. [180] showed that CNF composites with SiO2 particles have high surface area and flexibility. Waisi, Al-Jubouri and McCutcheon [180] did not evaluate the fibers’ biological characteristics, but Nekounam, et al. [181] produced CNF containing SiO2 nanoparticles by ES and observed that the incorporation of SiO2 nanoparticles increases hydrophilicity and improves cell attachment and viability. The carbon/silica nanofibers showed an increase in the proliferation rate of MG-63, indicating the strong osteoactive behavior of this compound.
In previous studies, Nekounam, et al. [182] also studied the influence of the incorporation of gold nanoparticles into CNF produced by two distinct methods: mixed electrospinning and simultaneously spun electrospinning/electrospraying. Indirect toxicity assays of MTT and lactate dehydrogenase (LDH) showed no significant toxicity that did not adversely affect cell proliferation. Samadian, et al. [117], in turn, deposited biomimetic HA crystals on electrospun CNF and studied the influence of the mineralization process. An increase in mechanical strength (p < 0.1) was reported, and the material transformed into one that was superhydrophilic and biocompatible. The produced compound induced higher new bone formation (61.3 ± 4.2%), when compared to the negative control group (p < 0.005).
In parallel with the development of ceramics for use in scaffolds aimed at bone regeneration, it has been observed, during the last two decades, the use of TII, such as Cu, Sr, Zn, Co, Si, and Bo, has the potential to increase bone formation and stimulate osteogenesis and angiogenesis [118,183]. Researchers have, also, observed [184,185] that some of these ions, such as Cu, Zn, and Ag, have anti-inflammatory and/or antibiotic action, which is very interesting with regard to bone grafts, in order to prevent inflammation and infections. In this context, studies [186] highlight that the use of these TII has advantages over the use of growth factors (organic molecules), such as the absence of decomposition risk, possibility of synergistic interaction between ions, and ability to be processed during the scaffold manufacture. Thus, doping/loading scaffolds with therapeutic ions has great potential for bone regeneration applications.
As highlighted before, the use of TII has been taking place since the beginning of the century, and has intensified in the last decade [116]. Examples of this include the doping of HA with Si [53,187], BG with Sr [188], and phosphate glasses with Mg [189]. In the last decade, the development of new bioactive glass compositions, containing ions such as Sr and Bo, has been observed [100], with it, also, being possible to highlight the addition of ions with bactericidal action, such as Zn and Sr, in a more comprehensive way in various bioceramics [76,190]. Figure 11 briefly demonstrates the important role of ceramic nanofibers and their various aspects, as well as the influence of TII in the bone-formation process.
In this sense, studies have focused on the production of ceramic nanofibers doped with therapeutic ions. Deliormanlı [191] prepared BG fibers (53% SiO2, 20% CaO, 6% Na2O, 12% K2O, 5% MgO and 4% P2O5) doped with cerium (Ce) and gallium (Ga) (1 to 5% by weight) through ES. Nanofibers exhibited good biocompatibility and the addition of Ce or Ga had no negative effect on the bioactivity in SBF. Moreover, tests on MC3T3-E1 pre-osteoblast cells using the MTT assay did not reveal nanofiber cytotoxicity in all the concentrations of the dopant element.
Weng, et al. [119] produced BG nanofibers (23.45% Si, 68.95% O, 2.28% P, 5.31% Ca; atom%) doped with Sr2+ and Cu2+ and observed that, when immersed in SBF, the presence of Sr promoted a fast formation of apatite crystals on the nanofibers’ surface, when compared to Cu-doped nanofibers. In in vitro cell culture, Sr significantly increased osteogenesis and suppressed osteoclastogenesis, while Cu promoted angiogenesis. These results corroborate with research that shows that Sr can help in bone homeostasis by stimulating osteoblasts, bone formation, and differentiation, as well as inhibiting osteoclastogenesis and bone resorption, in addition to exhibiting antimicrobial action [75,120,192]. Cu, in turn, may have an antibacterial effect and stimulate the proliferation of endothelial cells [193,194].
Tsai et al. [89] fabricated porous HA-CaO composite nanofibers loaded with Tetracycline (TC), presenting an average diameter of 461 ± 186 nm, which exhibited good drug-loading efficiency with the ability to delay the burst release of TC and maintain antibacterial activity, inhibiting bacterial growth for a seven-day period. Moreover, an outstanding drug-loading efficiency, a delay in the burst release of TC, and a maintenance in the antibacterial activity against Gram-positive bacteria Staphylococcus aureus and Gram-negative bacteria Pseudomonas aeruginosa were, also, observed in another work by Tsai, et al. [195], with Sr-substituted HA– CaO-CaCO3 nanofibers for over three weeks.
Zheng et al. (2021) developed nanofibrous scaffolds made of BaTiO3 doped with Ca2+ and Mn4+ by ES. After calcination at 1000 °C, the nanofibers exhibited a d33 (piezoelectric coefficient) close to that of native bone. This study also indicated that doping with Ca can accelerate the degradation rate of BaTiO3, while doping with Mn can reduce this degradation rate. From Figure 12, it can be seen through quantitative analysis (ALP, COL-I) and smeared color depth (ALP, calcium modulus), that, when compared to TCPs, marker expressions were higher for cells grown in doped nanofibers. In addition, all ion-doped BaTiO3 nanofibers exhibited a greater ability to accelerate cell differentiation. In addition, BaTiO3 nanofibers co-doped with Mn4+ (2 mol%) and Ca2+ (10 mol%) did not exhibit any cytotoxicity and achieved the greatest ability to increase osteogenic differentiation of BMSCs, corroborating with studies [121,196] that showed that Mn and Ca doping do not promote toxicity, once both elements are inherent to human bone, in addition to being effective in promoting osteogenesis.
Considering what has been exposed about ceramic nanofibers for bone regeneration applications, Table 2 shows important information about the main groups of ceramic nanofibers used for bone regeneration and their most relevant biological properties, mentioning some relevant studies addressing this subject over the last decade.

4. Future Perspectives

Different types of biomaterials made of ceramic nanofibers have been studied for wound healing and bone tissue regeneration, with numerous advances in these materials’ development. Despite that, there are still limited data available in the literature addressing ceramic nanofiber application in regenerative medicine. This fact is related to the difficulty of the usual techniques for the production of nanofibers, notably the production volume, in addition to the fact that many of the ceramic fibers produced by these techniques have high fragility, which makes it impossible to produce materials with the necessary strength for handling and application such as a scaffold or a membrane.
Despite being brittle, scaffolds made from fibrous bioceramic materials are an excellent alternative for the application in biomedical tissue engineering; when compared to polymeric scaffolds, they have the ability to form an interface with living tissue through physical and chemical interactions, exhibiting good bioactivity. A majority of the studies involving the production of nanofibrious ceramic scaffolds observed an association between the inherent characteristics of the nanometric character of the microstructure (fiber topography, nanofiber arrangement, size, pore distribution, etc.) and the chemical–biological properties of the materials, often with a synergism between them, which usually implies outstanding cell adhesion, proliferation, and differentiation in in vitro tests.
Among the widely used ceramic materials, the use of SiO2 nanofibers can be highlighted due to their outstanding mechanical strength, large specific surface area, and good biocompatibility. CaP nanofibers are also widely used in several biomedical applications, due to their biocompatibility, bioactivity properties, and good osteoconduction and osseointegration characteristics.
Recent studies have demonstrated that the incorporation of inorganic therapeutic agents in nanofibrous ceramic systems is one of the new horizons of the regenerative medicine to improve biocompatibility, biodegradability, antimicrobial activity, wound-healing capacity, and bone -regeneration action.

Author Contributions

Conceptualization, D.d.S.G., R.d.S.V. and R.R.M.; formal analysis and writing, D.d.S.G., R.d.S.V. and R.R.M.; review and supervision, R.R.M., B.V.d.S., L.N.d.L.S. and G.d.A.N.; project administration and funding acquisition, R.R.M. and G.d.A.N. All authors have read and agreed to the published version of the manuscript.

Funding

The authors are grateful to the National Council for Scientific and Technological Development (Conselho Nacional de Desen-volvimento Científico e Tecnologico–CNPq), grant nos. 140371/2019-2 (D.d.S.G.), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior–Brasil (CAPES)–Finance Code 001 (R.d.S.V.) and National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Científico e Tecnologico–CNPq), 420004/2018-1 and 309771/2021-8 (R.R.M.)

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Lauren, C.T. Bone Gratf Substitutes; ASTM International e American Academy of Orthopaedic Surgeons: West Conshohocken, PA, USA, 2003. [Google Scholar]
  2. World Health Organization (WHO). Available online: https://www.who.int/news-room/fact-sheets/detail/diabetes (accessed on 15 November 2021).
  3. Ribas, R.G.; Schatkoski, V.M.; do Amaral Montanheiro, T.L.; De Menezes, B.R.C.; Stegemann, C.; Leite, D.M.G.; Thim, G.P. Current advances in bone tissue engineering concerning ceramic and bioglass scaffolds: A review. Ceram. Int. 2019, 45, 21051–21061. [Google Scholar] [CrossRef]
  4. Qu, H.; Fu, H.; Han, Z.; Sun, Y. Biomaterials for bone tissue engineering scaffolds: A review. RSC Adv. 2019, 9, 26252–26262. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. World Health Organization (WHO). Available online: https://www.who.int/nutrition/topics/5_population_nutrient/en/index25.html (accessed on 19 November 2021).
  6. Kalyani, R.R.; Golden, S.H.; Cefalu, W.T. Diabetes and aging: Unique considerations and goals of care. Diabetes Care 2017, 40, 440–443. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Homaeigohar, S.; Boccaccini, A.R. Antibacterial biohybrid nanofibers for wound dressings. Acta Biomater. 2020, 107, 25–49. [Google Scholar] [CrossRef] [PubMed]
  8. Memic, A.; Abudula, T.; Mohammed, H.S.; Joshi Navare, K.; Colombani, T.; Bencherif, S.A. Latest progress in electrospun nanofibers for wound healing applications. ACS Appl. Bio. Mater. 2019, 2, 952–969. [Google Scholar] [CrossRef]
  9. Sylvester, M.A.; Amini, F.; Tan, C.K. Electrospun nanofibers in wound healing. Mater. Today Proc. 2020, 29, 1–6. [Google Scholar] [CrossRef]
  10. Caffrey, M. Diabetic Amputations My Be Rising in the United States. Available online: https://www.ajmc.com/view/diabetic-amputations-may-be-rising-in-the-united-states (accessed on 25 November 2021).
  11. Haugen, H.J.; Lyngstadaas, S.P.; Rossi, F.; Perale, G. Bone grafts: Which is the ideal biomaterial? J. Clin. Periodontol. 2019, 46, 92–102. [Google Scholar] [CrossRef]
  12. Miguel, S.P.; Figueira, D.R.; Simões, D.; Ribeiro, M.P.; Coutinho, P.; Ferreira, P.; Correia, I.J. Electrospun polymeric nanofibres as wound dressings: A review. Colloids Surf. B Biointerfaces 2018, 169, 60–71. [Google Scholar] [CrossRef]
  13. Simões, D.; Miguel, S.P.; Ribeiro, M.P.; Coutinho, P.; Mendonça, A.G.; Correia, I.J. Recent advances on antimicrobial wound dressing: A review. Eur. J. Pharm. Biopharm. 2018, 127, 130–141. [Google Scholar] [CrossRef]
  14. Figliomeni, A.; Signorini, V.; Mazzantini, M. One year in review 2018: Progress in osteoporosis treatment. Clin. Exp. Rheumatol. 2018, 36, 948–958. [Google Scholar]
  15. Iaquinta, M.R.; Mazzoni, E.; Manfrini, M.; D’Agostino, A.; Trevisiol, L.; Nocini, R.; Trombelli, L.; Barbanti-Brodano, G.; Martini, F.; Tognon, M. Innovative biomaterials for bone regrowth. Int. J. Mol. Sci. 2019, 20, 618. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Engel, E.; Michiardi, A.; Navarro, M.; Lacroix, D.; Planell, J.A. Nanotechnology in regenerative medicine: The materials side. Trends Biotechnol. 2008, 26, 39–47. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Mouriño, V.; Cattalini, J.P.; Roether, J.A.; Dubey, P.; Roy, I.; Boccaccini, A.R. Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering. Exp. Opin. Drug Deliv. 2013, 10, 1353–1365. [Google Scholar] [CrossRef]
  18. Suárez-Franco, J.L.; García-Hipólito, M.; Surárez-Rosales, M.Á.; Fernández-Pedrero, J.A.; Álvarez-Fregoso, O.; Juárez-Islas, J.A.; Álvarez-Pérez, M.A. Effects of Surface Morphology of Ceramic Materials on Osteoblastic Cells Responses. J. NanoMater. 2013, 2013, 2. [Google Scholar] [CrossRef] [Green Version]
  19. Lim, C.T. Nanofiber technology: Current status and emerging developments. Prog. Polymer. Sci. 2017, 70, 1–17. [Google Scholar]
  20. Das, I.; De, G.; Hupa, L.; Vallittu, P.K. Porous SiO2 nanofiber grafted novel bioactive glass–ceramic coating: A structural scaffold for uniform apatite precipitation and oriented cell proliferation on inert implant. Mater. Sci. Eng. C 2016, 62, 206–214. [Google Scholar] [CrossRef] [PubMed]
  21. Elangomannan, S.; Louis, K.; Dharmaraj, B.M.; Kandasamy, V.S.; Soundarapandian, K.; Gopi, D. Carbon nanofiber/polycaprolactone/mineralized hydroxyapatite nanofibrous scaffolds for potential orthopedic applications. ACS Appl. Mater. Interfaces 2017, 9, 6342–6355. [Google Scholar] [CrossRef]
  22. Penide, J.; Quintero, F.; del Val, J.; Comesaña, R.; Lusquiños, F.; Riveiro, A.; Pou, J. Bioactive glass nanofibers for tissue engineering. In Materials for Biomedical Engineering; Elsevier: Amsterdam, The Netherlands, 2019; pp. 329–356. [Google Scholar]
  23. Medeiros, E.L.; Gomes, D.S.; Santos, A.M.; Vieira, R.H.; de Lima, I.L.; Rocha, F.S.; Castro-Filice, L.D.S.; Medeiros, E.S.; Neves, G.A.; Menezes, R.R. 3D nanofibrous bioactive glass scaffolds produced by one-step spinning process. Ceram. Int. 2021, 47, 102–110. [Google Scholar] [CrossRef]
  24. Zhang, Y.; Li, J.; Soleimani, M.; Giacomini, F.; Friedrich, H.; Truckenmüller, R.; Habibovic, P. Biodegradable Elastic Sponge from Nanofibrous Biphasic Calcium Phosphate Ceramic as an Advanced Material for Regenerative Medicine. Adv. Funct. Mater. 2021, 31, 2102911. [Google Scholar] [CrossRef]
  25. Tan, A.W.; Pingguan-Murphy, B.; Ahmad, R.; Akbar, S.A. Advances in fabrication of TiO2 nanofiber/nanowire arrays toward the cellular response in biomedical implantations: A review. J. Mater. Sci. 2013, 48, 8337–8353. [Google Scholar] [CrossRef]
  26. Shitole, A.A.; Raut, P.W.; Sharma, N.; Giram, P.; Khandwekar, A.P.; Garnaik, B. Electrospun polycaprolactone/hydroxyapatite/ZnO nanofibers as potential biomaterials for bone tissue regeneration. J. Mater. Sci. Mater. Med. 2019, 30, 1–17. [Google Scholar] [CrossRef] [PubMed]
  27. Rana, D.; Ramalingam, M. Ceramic nanofiber composites. In Nanofiber Composites for Biomedical Applications; Elsevier: Amsterdam, The Netherlands, 2017; pp. 33–54. [Google Scholar]
  28. Kim, H.W.; Kim, H.E.; Knowles, J.C. Production and potential of bioactive glass nanofibers as a next-generation biomaterial. Adv. Funct. Mater. 2006, 16, 1529–1535. [Google Scholar] [CrossRef]
  29. Xia, W.; Zhang, D.; Chang, J. Fabrication and in vitro biomineralization of bioactive glass (BG) nanofibres. Nanotechnology 2007, 18, 135601. [Google Scholar] [CrossRef] [PubMed]
  30. Kim, H.W.; Kim, H.E. Nanofiber generation of hydroxyapatite and fluor-hydroxyapatite bioceramics. J. Biomed. Mater. Res. Part B Appl. Biomater. Off. J. Soc. Biomater. Jap. Soc. Biomater. Aust. Soc. Biomater. Korean Soc. Biomater. 2006, 77, 323–328. [Google Scholar] [CrossRef] [PubMed]
  31. Gazquez, G.C.; Chen, H.; Moroni, L.; Boukamp, B.A.; Johan, E. β-Tricalcium phosphate nanofiber scaffolds with fine unidirectional grains. Mater. Lett. 2017, 208, 118–121. [Google Scholar] [CrossRef]
  32. Xiao, J.; Wan, Y.; Yao, F.; Huang, Y.; Zhu, Y.; Yang, Z.; Luo, H. Constructing 3D scaffold with 40-nm-diameter hollow mesoporous bioactive glass nanofibers. Mater. Lett. 2019, 248, 201–203. [Google Scholar] [CrossRef]
  33. Alghoraibi, I.; Alomari, S. Different methods for nanofiber design and fabrication. In Handbook of Nanofibers; Springer: Cham, Switzerland, 2018; pp. 1–46. [Google Scholar]
  34. Nayak, R.; Padhye, R.; Kyratzis, I.L.; Truong, Y.B.; Arnold, L. Recent advances in nanofibre fabrication techniques. Text. Res. J. 2012, 82, 129–147. [Google Scholar] [CrossRef]
  35. Luiten-Olieman, M.W.J.; Winnubst, L.; Nijmeijer, A.; Wessling, M.; Benes, N.E. Porous stainless steel hollow fiber membranes via dry–wet spinning. J. Membr. Sci. 2011, 370, 124–130. [Google Scholar] [CrossRef]
  36. Yaari, A.; Schilt, Y.; Tamburu, C.; Raviv, U.; Shoseyov, O. Wet spinning and drawing of human recombinant collagen. ACS BioMater. Sci. Eng. 2016, 2, 349–360. [Google Scholar] [CrossRef]
  37. Kim, S.-W.; Kwon, S.-N.; Na, S.-I. Stretchable and electrically conductive polyurethane-silver/graphene composite fibers prepared by wet-spinning process. Compos. Part B Eng. 2019, 167, 573–581. [Google Scholar] [CrossRef]
  38. Mohanty, S.; Rameshbabu, A.P.; Dhara, S. α-Alumina fiber with platelet morphology through wet spinning. J. Am. Ceramic Soc. 2012, 95, 1234–1240. [Google Scholar] [CrossRef]
  39. Dadol, G.C.; Kilic, A.; Tijing, L.D.; Lim, K.J.A.; Cabatingan, L.K.; Tan, N.P.B.; Stojanovska, E.; Polat, Y. Solution blow spinning (SBS) and SBS-spun nanofibers: Materials, methods, and applications. Mater. Today Commun. 2020, 25, 101656. [Google Scholar] [CrossRef]
  40. Guo, Y.; Jian, X.; Zhang, L.; Mu, C.; Yin, L.; Xie, J.; Mahmood, N.; Dou, S.; Che, R.; Deng, L. Plasma-induced FeSiAl@ Al2O3@ SiO2 core–shell structure for exceptional microwave absorption and anti-oxidation at high temperature. Chem. Eng. J. 2020, 384, 123371. [Google Scholar] [CrossRef]
  41. Sista, D. New Perspective of Nano Fibers: Synthesis and Applications. In Nanofibers; Intechopen: London, UK, 2021. [Google Scholar]
  42. Yonezawa, T.; Čempel, D.; Nguyen, M.T. Microwave-induced plasma-in-liquid process for nanoparticle production. Bull. Chem. Soc. Jap. 2018, 91, 1781–1798. [Google Scholar] [CrossRef]
  43. Weitz, R.T.; Harnau, L.; Rauschenbach, S.; Burghard, M.; Kern, K. Polymer nanofibers via nozzle-free centrifugal spinning. Nano Lett. 2008, 8, 1187–1191. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Ren, L.; Kotha, S.P. Centrifugal jet spinning for highly efficient and large-scale fabrication of barium titanate nanofibers. Mater. Lett. 2014, 117, 153–157. [Google Scholar] [CrossRef] [Green Version]
  45. Aminirastabi, H.; Weng, Z.; Xue, H.; Yu, Y.; Ji, G.; Mitic, V.V.; Guan, R. Evaluation of nano grain growth of TiO2 fibers fabricated via centrifugal jet spinning. Nano Struct. Nano Obj. 2020, 21, 100413. [Google Scholar] [CrossRef]
  46. Zhang, X.; Lu, Y. Centrifugal spinning: An alternative approach to fabricate nanofibers at high speed and low cost. Polym. Rev. 2014, 54, 677–701. [Google Scholar] [CrossRef]
  47. Noroozi, S.; Taghavi, S.M. 5 Ultrafine Nanofiber Formation by Centrifugal Spinning. In Advanced Materials; De Gruyter: Berlin, Germany, 2020; p. 143. [Google Scholar]
  48. Khalili, S.; Chenari, H.M. Successful electrospinning fabrication of ZrO2 nanofibers: A detailed physical–chemical characterization study. J. Alloys Compd. 2020, 828, 154414. [Google Scholar] [CrossRef]
  49. Wen, Z.; Song, X.; Chen, D.; Fan, T.; Liu, Y.; Cai, Q. Electrospinning preparation and microstructure characterization of homogeneous diphasic mullite ceramic nanofibers. Ceram. Int. 2020, 46, 12172–12179. [Google Scholar] [CrossRef]
  50. Calisir, M.D.; Kilic, A. A comparative study on SiO2 nanofiber production via two novel non-electrospinning methods: Centrifugal spinning vs. solution blowing. Mater. Lett. 2020, 258, 126751. [Google Scholar] [CrossRef]
  51. Xue, J.; Xie, J.; Liu, W.; Xia, Y. Electrospun nanofibers: New concepts, materials, and applications. Acc. Chem. Res. 2017, 50, 1976–1987. [Google Scholar] [CrossRef] [PubMed]
  52. Ashraf, R.; Sofi, H.S.; Akram, T.; Rather, H.A.; Abdal-hay, A.; Shabir, N.; Vasita, R.; Alrokayan, S.H.; Khan, H.A.; Sheikh, F.A. Fabrication of multifunctional cellulose/TiO2/Ag composite nanofibers scaffold with antibacterial and bioactivity properties for future tissue engineering applications. J. Biomed. Mater. Res. Part A 2020, 108, 947–962. [Google Scholar] [CrossRef] [PubMed]
  53. Balas, F.; Perez-Pariente, J.; Vallet-Regi, M. In vitro bioactivity of silicon-substituted hydroxyapatites. J. Biomed. Mater. Res. Part B Appl. Biomater. Off. J. Soc. Biomater. Jap. Soc. Biomater. Aust. Soc. Biomater. Korean Soc. Biomater. 2003, 66, 364–375. [Google Scholar]
  54. Cheng, D.; Liu, D.; Tang, T.; Zhang, X.; Jia, X.; Cai, Q.; Yang, X. Effects of Ca/P molar ratios on regulating biological functions of hybridized carbon nanofibers containing bioactive glass nanoparticles. Biomed. Mater. 2017, 12, 025019. [Google Scholar] [CrossRef] [PubMed]
  55. Luo, H.; Li, W.; Ao, H.; Li, G.; Tu, J.; Xiong, G.; Zhu, Y.; Wan, Y. Preparation, structural characterization, and in vitro cell studies of three-dimensional SiO2–CaO binary glass scaffolds built ofultra-small nanofibers. Mater. Sci. Eng. C 2017, 76, 94–101. [Google Scholar] [CrossRef]
  56. Oliveira, M.J.C.D.; Bonan, R.F.; Campos, S.G.; Neves, G.D.A.; Menezes, R.R. Calcium phosphate submicrometric fibers produced by solution blow spinning. Mater. Res. 2019, 22. [Google Scholar] [CrossRef]
  57. Mota, M.; Santos, A.; Farias, R.; Neves, G.; Menezes, R. Synthesis and characterization of alumina fibers using solution blow spinning. Cerâmica 2019, 65, 190–193. [Google Scholar] [CrossRef]
  58. Ding, J.; Zhang, J.; Li, J.; Li, D.; Xiao, C.; Xiao, H.; Yang, H.; Zhuang, X.; Chen, X. Electrospun polymer biomaterials. Progr. Polym. Sci. 2019, 90, 1–34. [Google Scholar] [CrossRef]
  59. Moeini, A.; Pedram, P.; Makvandi, P.; Malinconico, M.; d’Ayala, G.G. Wound healing and antimicrobial effect of active secondary metabolites in chitosan-based wound dressings: A review. Carbohydr. Polym. 2020, 233, 115839. [Google Scholar] [CrossRef]
  60. Gangawane, A.; Bhatt, B.; Sunmeet, M. Skin infections in diabetes: A review. Diabetes Metab. 2016, 7, 130–141. [Google Scholar]
  61. Rezvani Ghomi, E.; Khalili, S.; Nouri Khorasani, S.; Esmaeely Neisiany, R.; Ramakrishna, S. Wound dressings: Current advances and future directions. J. Appl. Polymer. Sci. 2019, 136, 47738. [Google Scholar] [CrossRef] [Green Version]
  62. Gao, Y.; Zhang, J.; Su, Y.; Wang, H.; Wang, X.-X.; Huang, L.-P.; Yu, M.; Ramakrishna, S.; Long, Y.-Z. Recent progress and challenges in solution blow spinning. Mater. Horiz. 2021, 8, 426–446. [Google Scholar] [CrossRef] [PubMed]
  63. Li, W.J.; Laurencin, C.T.; Caterson, E.J.; Tuan, R.S.; Ko, F.K. Electrospun nanofibrous structure: A novel scaffold for tissue engineering. J. Biomed. Mater. Res. Part B Appl. Biomater. Off. J. Soc. Biomater. Jap. Soc. Biomater. Aust. Soc. Biomater. Korean Soc. Biomater. 2002, 60, 613–621. [Google Scholar] [CrossRef]
  64. Barnes, C.P.; Sell, S.A.; Boland, E.D.; Simpson, D.G.; Bowlin, G.L. Nanofiber technology: Designing the next generation of tissue engineering scaffolds. Adv. Drug Deliv. Rev. 2007, 59, 1413–1433. [Google Scholar] [CrossRef]
  65. Zhong, S.P.; Zhang, Y.Z.; Lim, C.T. Tissue scaffolds for skin wound healing and dermal reconstruction. Wiley Interdisc. Rev. Nanomed. Nanobiotechnol. 2010, 2, 510–525. [Google Scholar] [CrossRef]
  66. Shahhosseininia, M.; Bazgir, S.; Joupari, M.D. Fabrication and investigation of silica nanofibers via electrospinning. Mater. Sci. Eng. C 2018, 91, 502–511. [Google Scholar] [CrossRef]
  67. Wan, M.; Zhao, H.; Peng, L.; Zhao, Y.; Sun, L. Facile One-Step Deposition of Ag Nanoparticles on SiO2 Electrospun Nanofiber Surfaces for Label-Free SERS Detection and Antibacterial Dressing. ACS Appl. Bio. Mater. 2021, 4, 6549–6557. [Google Scholar] [CrossRef]
  68. Norris, E.; Ramos-Rivera, C.; Poologasundarampillai, G.; Clark, J.P.; Ju, Q.; Obata, A.; Hanna, J.V.; Kasuga, T.; Mitchell, C.A.; Jell, G. Electrospinning 3D bioactive glasses for wound healing. Biomed. Mater. 2020, 15, 015014. [Google Scholar] [CrossRef]
  69. Solanki, A.K.; Lali, F.V.; Autefage, H.; Agarwal, S.; Nommeots-Nomm, A.; Metcalfe, A.D.; Stevens, M.M.; Jones, J.R. Bioactive glasses and electrospun composites that release cobalt to stimulate the HIF pathway for wound healing applications. BioMater. Res. 2021, 25, 1–16. [Google Scholar] [CrossRef]
  70. Garibay-Alvarado, J.A.; Espinosa-Cristóbal, L.F.; Reyes-López, S.Y. Fibrous silica-hydroxyapatite composite by electrospinning. Int. J. Res. Granthaalayah 2017, 5, 39–47. [Google Scholar] [CrossRef]
  71. Ahmed, M.K.; Ramadan, R.; El-Dek, S.I.; Uskoković, V. Complex relationship between alumina and selenium-doped carbonated hydroxyapatite as the ceramic additives to electrospun polycaprolactone scaffolds for tissue engineering applications. J. Alloys Comp. 2019, 801, 70–81. [Google Scholar] [CrossRef]
  72. Ma, Z.; Ji, H.; Tan, D.; Teng, Y.; Dong, G.; Zhou, J.; Qiu, J.; Zhang, M. Silver nanoparticles decorated, flexible SiO2 nanofibers with long-term antibacterial effect as reusable wound cover. Colloids Surf. A Physicochem. Eng. Asp. 2011, 387, 57–64. [Google Scholar] [CrossRef]
  73. Yamaguchi, T.; Sakai, S.; Kawakami, K. Application of silicate electrospun nanofibers for cell culture. J. Sol. Gel Sci. Technol. 2008, 48, 350–355. [Google Scholar] [CrossRef]
  74. Garibay-Alvarado, J.A.; Herrera-Ríos, E.B.; Vargas-Requena, C.L.; de Jesús Ruíz-Baltazar, Á.; Reyes-López, S.Y. Cell behavior on silica-hydroxyapatite coaxial composite. PLoS ONE 2021, 16, e0246256. [Google Scholar] [CrossRef]
  75. Kaur, G. Clinical Applications of Biomaterials: State-of-the-Art Progress, Trends, and Novel Approaches; Springer: Cham, Switzerland, 2017. [Google Scholar]
  76. Ranga, N.; Gahlyan, S.; Duhan, S. Antibacterial efficiency of Zn, Mg and Sr doped bioactive glass for bone tissue engineering. J. NanoSci. Nanotechnol. 2020, 20, 2465–2472. [Google Scholar] [CrossRef]
  77. Firmino, H.C.; Nascimento, E.P.; Bonan, R.F.; Maciel, P.P.; Castellano, L.R.; Santana, L.N.; Neves, G.A.; Menezes, R.R. Antifungal activity of TiO2-CeO2 nanofibers against Candida fungi. Mater. Lett. 2021, 283, 128709. [Google Scholar] [CrossRef]
  78. Safiaghdam, H.; Nokhbatolfoghahaei, H.; Khojasteh, A. Therapeutic metallic ions in bone tissue engineering: A systematic review of the literature. Iran. J. Pharm. Res. IJPR 2019, 18, 101. [Google Scholar]
  79. Alberti, T.; Coelho, D.; Voytena, A.; Pitz, H.; De Pra, M.; Mazzarino, L.; Kuhnen, S.; Ribeiro-do-Valle, R.; Maraschin, M.; Veleirinho, B. Nanotechnology: A promising tool towards wound healing. Curr. Pharm. Des. 2017, 23, 3515–3528. [Google Scholar] [CrossRef]
  80. Zhang, Q.; Wang, Y.; Zhang, W.; Hickey, M.E.; Lin, Z.; Tu, Q.; Wang, J. In situ assembly of well-dispersed Ag nanoparticles on the surface of polylactic acid-Au@ polydopamine nanofibers for antimicrobial applications. Colloids Surf. B Biointer. 2019, 184, 110506. [Google Scholar] [CrossRef]
  81. Münchow, E.A.; Pankajakshan, D.; Albuquerque, M.T.P.; Kamocki, K.; Piva, E.; Gregory, R.L.; Bottino, M.C. Synthesis and characterization of CaO-loaded electrospun matrices for bone tissue engineering. Clin. Oral Inv. 2016, 20, 1921–1933. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  82. Liu, X.; Rahaman, M.N.; Day, D.E. In vitro degradation and conversion of melt-derived Microfibrous borate (13-93B3) bioactive glass doped with metal ions. J. Am. Ceram. Soc. 2014, 97, 3501–3509. [Google Scholar] [CrossRef]
  83. Ostomel, T.A.; Shi, Q.; Tsung, C.K.; Liang, H.; Stucky, G.D. Spherical bioactive glass with enhanced rates of hydroxyapatite deposition and hemostatic activity. Small 2006, 2, 1261–1265. [Google Scholar] [CrossRef] [PubMed]
  84. Tokoro, S.; Satoh, T.; Okubo, Y.; Igawa, K.; Yokozeki, H. Latent dystrophic subcutaneous calcification in patients with chronic venous insufficiency. Acta Derm. Venereol. 2009, 89, 505–508. [Google Scholar] [CrossRef]
  85. Wollina, U.; Hasenöhrl, K.; Köstler, E.; Schönlebe, J.; Heinig, B.; Haroske, G.; Kittner, T. Dystrophic calcification in chronic leg ulcers—A clinicopathologic study. Dermatol. Surg. 2009, 35, 457–461. [Google Scholar] [CrossRef]
  86. Milas, M.; Bush, R.L.; Lin, P.; Brown, K.; Mackay, G.; Lumsden, A.; Weber, C.; Dodson, T.F. Calciphylaxis and nonhealing wounds: The role of the vascular surgeon in a multidisciplinary treatment. J. Vasc. Surg. 2003, 37, 501–507. [Google Scholar] [CrossRef] [Green Version]
  87. Jung, S.B.; Day, D.E. Scaffolds with Trace Element for Tissue Regeneration in Mammals. U.S. Patent No. 8,287,896, 16 October 2012. [Google Scholar]
  88. Saha, S.; Bhattacharjee, A.; Rahaman, S.H.; Ray, S.; Marei, M.K.; Jain, H.; Chakraborty, J. Prospects of antibacterial bioactive glass nanofibers for wound healing: An in vitro study. Int. J. Appl. Glass Sci. 2020, 11, 320–328. [Google Scholar] [CrossRef]
  89. Tsai, S.-W.; Huang, S.-S.; Yu, W.-X.; Hsu, Y.-W.; Hsu, F.-Y. Fabrication and characteristics of porous hydroxyapatite-CaO composite nanofibers for biomedical applications. NanoMaterials 2018, 8, 570. [Google Scholar] [CrossRef] [Green Version]
  90. Gérard, C.; Bordeleau, L.-J.; Barralet, J.; Doillon, C.J. The stimulation of angiogenesis and collagen deposition by copper. BioMaterials 2010, 31, 824–831. [Google Scholar] [CrossRef]
  91. Barralet, J.; Gbureck, U.; Habibovic, P.; Vorndran, E.; Gerard, C.; Doillon, C.J. Angiogenesis in calcium phosphate scaffolds by inorganic copper ion release. Tissue Eng. Part A 2009, 15, 1601–1609. [Google Scholar] [CrossRef]
  92. Zhao, S.; Wang, H.; Zhang, Y.; Huang, W.; Rahaman, M.N.; Liu, Z.; Wang, D.; Zhang, C. RETRACTED: Copper-doped borosilicate bioactive glass scaffolds with improved angiogenic and osteogenic capacity for repairing osseous defects. Acta Biomater. 2015, 14, 185–196. [Google Scholar] [CrossRef] [PubMed]
  93. Giavaresi, G.; Torricelli, P.; Fornasari, P.; Giardino, R.; Barbucci, R.; Leone, G. Blood vessel formation after soft-tissue implantation of hyaluronan-based hydrogel supplemented with copper ions. BioMaterials 2005, 26, 3001–3008. [Google Scholar] [CrossRef] [PubMed]
  94. Gorter, R.W.; Butorac, M.; Cobian, E.P. Examination of the cutaneous absorption of copper after the use of copper-containing ointments. Am. J. Therap. 2004, 11, 453–458. [Google Scholar] [CrossRef] [PubMed]
  95. Borkow, G.; Gabbay, J.; Lyakhovitsky, A.; Huszar, M. Improvement of facial skin characteristics using copper oxide containing pillowcases: A double-blind, placebo-controlled, parallel, randomized study. Int. J. Cosmet. Sci. 2009, 31, 437–443. [Google Scholar] [CrossRef]
  96. Zhao, S.; Li, L.; Wang, H.; Zhang, Y.; Cheng, X.; Zhou, N.; Rahaman, M.N.; Liu, Z.; Huang, W.; Zhang, C. Wound dressings composed of copper-doped borate bioactive glass microfibers stimulate angiogenesis and heal full-thickness skin defects in a rodent model. BioMaterials 2015, 53, 379–391. [Google Scholar] [CrossRef]
  97. Alonzo, M.; Primo, F.A.; Kumar, S.A.; Mudloff, J.A.; Dominguez, E.; Fregoso, G.; Ortiz, N.; Weiss, W.M.; Joddar, B. Bone tissue engineering techniques, advances, and scaffolds for treatment of bone defects. Curr. Opin. Biomed. Eng. 2021, 17, 100248. [Google Scholar] [CrossRef]
  98. Turnbull, G.; Clarke, J.; Picard, F.; Riches, P.; Jia, L.; Han, F.; Li, B.; Shu, W. 3D bioactive composite scaffolds for bone tissue engineering. Bioact. Mater. 2018, 3, 278–314. [Google Scholar] [CrossRef] [Green Version]
  99. Rahman, M.A.; Islam, M.S.; Haque, P.; Khan, M.N.; Takafuji, M.; Begum, M.; Chowdhury, G.W.; Khan, M.; Rahman, M.M. Calcium ion mediated rapid wound healing by nano-ZnO doped calcium phosphate-chitosan-alginate biocomposites. Materialia 2020, 13, 100839. [Google Scholar] [CrossRef]
  100. Mouriño, V.; Vidotto, R.; Cattalini, J.; Boccaccini, A. Enhancing biological activity of bioactive glass scaffolds by inorganic ion delivery for bone tissue engineering. Curr. Opin. Biomed. Eng. 2019, 10, 23–34. [Google Scholar] [CrossRef]
  101. Antoniac, I.V. Handbook of Bioceramics and Biocomposites; Springer: Berlin, Germany, 2016. [Google Scholar]
  102. Wu, Y.; Jiang, W.; Wen, X.; He, B.; Zeng, X.; Wang, G.; Gu, Z. A novel calcium phosphate ceramic–magnetic nanoparticle composite as a potential bone substitute. Biomed. Mater. 2010, 5, 015001. [Google Scholar] [CrossRef]
  103. Wen, W.; Zou, Z.; Luo, B.; Zhou, C. In vitro degradation and cytocompatibility of g-MgO whiskers/PLLA composites. J. Mater. Sci. 2017, 52, 2329–2344. [Google Scholar] [CrossRef]
  104. Xing, X.; Cheng, G.; Yin, C.; Cheng, X.; Cheng, Y.; Ni, Y.; Zhou, X.; Deng, H.; Li, Z. Magnesium-containing silk fibroin/polycaprolactone electrospun nanofibrous scaffolds for accelerating bone regeneration. Arab. J. Chem. 2020, 13, 5526–5538. [Google Scholar] [CrossRef]
  105. Shalumon, K.; Sowmya, S.; Sathish, D.; Chennazhi, K.; Nair, S.V.; Jayakumar, R. Effect of incorporation of nanoscale bioactive glass and hydroxyapatite in PCL/chitosan nanofibers for bone and periodontal tissue engineering. J. Biomed. Nanotechnol. 2013, 9, 430–440. [Google Scholar] [CrossRef] [PubMed]
  106. Gandolfi, M.G.; Zamparini, F.; Degli Esposti, M.; Chiellini, F.; Aparicio, C.; Fava, F.; Fabbri, P.; Taddei, P.; Prati, C. Polylactic acid-based porous scaffolds doped with calcium silicate and dicalcium phosphate dihydrate designed for biomedical application. Mater. Sci. Eng. C 2018, 82, 163–181. [Google Scholar] [CrossRef]
  107. Kharaziha, M.; Fathi, M.; Edris, H. Development of novel aligned nanofibrous composite membranes for guided bone regeneration. J. Mech. Beh. Biomed. Mater. 2013, 24, 9–20. [Google Scholar] [CrossRef] [PubMed]
  108. Augustine, A.; Augustine, R.; Hasan, A.; Raghuveeran, V.; Rouxel, D.; Kalarikkal, N.; Thomas, S. Development of titanium dioxide nanowire incorporated poly (vinylidene fluoride–trifluoroethylene) scaffolds for bone tissue engineering applications. J. Mater. Sci. Mater. Med. 2019, 30, 1–13. [Google Scholar] [CrossRef] [Green Version]
  109. Ramírez-Cedillo, E.; Ortega-Lara, W.; Rocha-Pizaña, M.R.; Gutierrez-Uribe, J.A.; Elías-Zúñiga, A.; Rodríguez, C.A. Electrospun polycaprolactone fibrous membranes containing Ag, TiO2 and Na2Ti6O13 particles for potential use in bone regeneration. Membranes 2019, 9, 12. [Google Scholar] [CrossRef] [Green Version]
  110. Bagchi, A.; Meka, S.R.K.; Rao, B.N.; Chatterjee, K. Perovskite ceramic nanoparticles in polymer composites for augmenting bone tissue regeneration. Nanotechnology 2014, 25, 485101. [Google Scholar] [CrossRef]
  111. Meng, J.; Zhang, Y.; Qi, X.; Kong, H.; Wang, C.; Xu, Z.; Xie, S.; Gu, N.; Xu, H. Paramagnetic nanofibrous composite films enhance the osteogenic responses of pre-osteoblast cells. Nanoscale 2010, 2, 2565–2569. [Google Scholar] [CrossRef]
  112. Wei, Y.; Zhang, X.; Song, Y.; Han, B.; Hu, X.; Wang, X.; Lin, Y.; Deng, X. Magnetic biodegradable Fe3O4/CS/PVA nanofibrous membranes for bone regeneration. Biomed. Mater. 2011, 6, 055008. [Google Scholar] [CrossRef] [Green Version]
  113. Dos Santos, V.; Brandalise, R.N.; Savaris, M. Engineering of Biomatterials; Springer: Cham, Switzerland, 2017. [Google Scholar]
  114. Wu, C.; Chang, J. Degradation, bioactivity, and cytocompatibility of diopside, akermanite, and bredigite ceramics. J. Biomed. Mater. Res. Part B Appl. Biomater. Off. J. Soc. Biomater. Jap. Soc. Biomater. Aust. Soc. Biomater. Korean Soc. Biomater. 2007, 83, 153–160. [Google Scholar] [CrossRef] [PubMed]
  115. Zhou, T.; Liu, X.; Sui, B.; Liu, C.; Mo, X.; Sun, J. Development of fish collagen/bioactive glass/chitosan composite nanofibers as a GTR/GBR membrane for inducing periodontal tissue regeneration. Biomed. Mater. 2017, 12, 055004. [Google Scholar] [CrossRef] [PubMed]
  116. Hoppe, A.; Güldal, N.S.; Boccaccini, A.R. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. BioMaterials 2011, 32, 2757–2774. [Google Scholar] [CrossRef]
  117. Samadian, H.; Mobasheri, H.; Azami, M.; Faridi-Majidi, R. Osteoconductive and electroactive carbon nanofibers/hydroxyapatite nanocomposite tailored for bone tissue engineering: In vitro and in vivo studies. Sci. Rep. 2020, 10, 1–14. [Google Scholar] [CrossRef] [PubMed]
  118. Habibovic, P.; Barralet, J. Bioinorganics and biomaterials: Bone repair. Acta Biomater. 2011, 7, 3013–3026. [Google Scholar] [CrossRef]
  119. Weng, L.; Boda, S.K.; Teusink, M.J.; Shuler, F.D.; Li, X.; Xie, J. Binary doping of strontium and copper enhancing osteogenesis and angiogenesis of bioactive glass nanofibers while suppressing osteoclast activity. ACS Appl. Mater. Int. 2017, 9, 24484–24496. [Google Scholar] [CrossRef] [PubMed]
  120. Bonnelye, E.; Chabadel, A.; Saltel, F.; Jurdic, P. Dual effect of strontium ranelate: Stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 2008, 42, 129–138. [Google Scholar] [CrossRef]
  121. Li, Y.; Pan, Q.; Xu, J.; He, X.; Li, H.A.; Oldridge, D.A.; Li, G.; Qin, L. Overview of methods for enhancing bone regeneration in distraction osteogenesis: Potential roles of biometals. J. Orthop. Trans. 2021, 27, 110–118. [Google Scholar] [CrossRef]
  122. Holopainen, J.; Ritala, M. Rapid production of bioactive hydroxyapatite fibers via electroblowing. J. Eur. Ceramic Soc. 2016, 36, 3219–3224. [Google Scholar] [CrossRef]
  123. Shin, M.; Yoshimoto, H.; Vacanti, J.P. In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng. 2004, 10, 33–41. [Google Scholar] [CrossRef]
  124. Pasuri, J.; Holopainen, J.; Kokkonen, H.; Persson, M.; Kauppinen, K.; Lehenkari, P.; Santala, E.; Ritala, M.; Tuukkanen, J. Osteoclasts in the interface with electrospun hydroxyapatite. Colloids Surf. B Biointer. 2015, 135, 774–783. [Google Scholar] [CrossRef] [PubMed]
  125. Hong, Y.; Chen, X.; Jing, X.; Fan, H.; Gu, Z.; Zhang, X. Fabrication and drug delivery of ultrathin mesoporous bioactive glass hollow fibers. Adv. Funct. Mater. 2010, 20, 1503–1510. [Google Scholar] [CrossRef]
  126. Tsai, S.-W.; Chang, Y.-H.; Yu, J.-L.; Hsu, H.-W.; Rau, L.-R.; Hsu, F.-Y. Preparation of nanofibrous structure of mesoporous bioactive glass microbeads for biomedical applications. Materials 2016, 9, 487. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  127. Lian, H.; Meng, Z. Fabrication, characterization and osteoblast responses of poly (octanediol citrate)/bioglass nanofiber composites. Mater. Sci. Eng. C 2018, 84, 123–129. [Google Scholar] [CrossRef]
  128. Du, Z.; Zhao, Z.; Liu, H.; Liu, X.; Zhang, X.; Huang, Y.; Leng, H.; Cai, Q.; Yang, X. Macroporous scaffolds developed from CaSiO3 nanofibers regulating bone regeneration via controlled calcination. Mater. Sci. Eng. C 2020, 113, 111005. [Google Scholar] [CrossRef]
  129. Dai, X.; Shivkumar, S. Electrospinning of PVA-Calcium Phosphate Sol Precursors for the Production of Fibrous Hydroxyapatite. J. Am. Ceramic Soc. 2007, 90, 1412–1419. [Google Scholar] [CrossRef]
  130. LeGeros, R.Z.; Legeros, J.P. Phosphate minerals in human tissues. In Phosphate Minerals; Springer: Berlin, Germany, 1984; pp. 351–385. [Google Scholar]
  131. Klein, C.P.; Patka, P.; Den Hollander, W. Macroporous calcium phosphate bioceramics in dog femora: A histological study of interface and biodegration. BioMaterials 1989, 10, 59–62. [Google Scholar] [CrossRef]
  132. Gauthier, O.; Goyenvalle, E.; Bouler, J.-M.; Guicheux, J.; Pilet, P.; Weiss, P.; Daculsi, G. Macroporous biphasic calcium phosphate ceramics versus injectable bone substitute: A comparative study 3 and 8 weeks after implantation in rabbit bone. J. Mater. Sci. Mater. Med. 2001, 12, 385–390. [Google Scholar] [CrossRef]
  133. Rahaman, M.N.; Day, D.E.; Bal, B.S.; Fu, Q.; Jung, S.B.; Bonewald, L.F.; Tomsia, A.P. Bioactive glass in tissue engineering. Acta Biomater. 2011, 7, 2355–2373. [Google Scholar] [CrossRef] [Green Version]
  134. Yi, Z.; Wang, K.; Tian, J.; Shu, Y.; Yang, J.; Xiao, W.; Li, B.; Liao, X. Hierarchical porous hydroxyapatite fibers with a hollow structure as drug delivery carriers. Ceram. Int. 2016, 42, 19079–19085. [Google Scholar] [CrossRef]
  135. Yuan, H.; Fernandes, H.; Habibovic, P.; De Boer, J.; Barradas, A.M.; De Ruiter, A.; Walsh, W.R.; Van Blitterswijk, C.A.; De Bruijn, J.D. Osteoinductive ceramics as a synthetic alternative to autologous bone grafting. Proc. Natl. Acad. Sci. USA 2010, 107, 13614–13619. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  136. Champion, E. Sintering of calcium phosphate bioceramics. Acta Biomater. 2013, 9, 5855–5875. [Google Scholar] [CrossRef] [PubMed]
  137. Jeong, J.; Kim, J.H.; Shim, J.H.; Hwang, N.S.; Heo, C.Y. Bioactive calcium phosphate materials and applications in bone regeneration. BioMater. Res. 2019, 23, 1–11. [Google Scholar]
  138. Basu, B.; Balani, K. Advanced Structural Ceramics; John Wiley & Sons: Hoboken, NJ, USA, 2011. [Google Scholar]
  139. Min, B.-M.; Lee, G.; Kim, S.H.; Nam, Y.S.; Lee, T.S.; Park, W.H. Electrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro. BioMaterials 2004, 25, 1289–1297. [Google Scholar] [CrossRef] [PubMed]
  140. Teixeira, A.I.; Nealey, P.F.; Murphy, C.J. Responses of human keratocytes to micro-and nanostructured substrates. J. Biomed. Mater. Res. Part B Appl. Biomater. Off. J. Soc. Biomater. Jap. Soc. Biomater. Aust. Soc. Biomater. Korean Soc. Biomater. 2004, 71, 369–376. [Google Scholar] [CrossRef]
  141. Yousefi, A.-M.; Oudadesse, H.; Akbarzadeh, R.; Wers, E.; Lucas-Girot, A. Physical and biological characteristics of nanohydroxyapatite and bioactive glasses used for bone tissue engineering. Nanotechnol. Rev. 2014, 3, 527–552. [Google Scholar] [CrossRef]
  142. Hench, L.L. Bioceramics: From concept to clinic. J. Am. Ceram. Soc. 1991, 74, 1487–1510. [Google Scholar] [CrossRef]
  143. Hench, L.L. Glass and glass-ceramic technologies to transform the world. Int. J. Appl. Glass Sci. 2011, 2, 162–176. [Google Scholar] [CrossRef]
  144. Jones, J.R. Review of bioactive glass: From Hench to hybrids. Acta Biomater. 2013, 9, 4457–4486. [Google Scholar] [CrossRef]
  145. Lobel, K.; Hench, L. In vitro adsorption and activity of enzymes on reaction layers of bioactive glass substrates. J. Biomed. Mater. Res. Part B Appl. Biomater. Off. J. Soc. Biomater. Jap. Soc. Biomater. Aust. Soc. Biomater. Korean Soc. Biomater. 1998, 39, 575–579. [Google Scholar]
  146. Ohgushi, H.; Dohi, Y.; Yoshikawa, T.; Tamai, S.; Tabata, S.; Okunaga, K.; Shibuya, T. Osteogenic differentiation of cultured marrow stromal stem cells on the surface of bioactive glass ceramics. J. Biomed. Mater. Res. Off. J. Soc. BioMater. Jap. Soc. BioMater. 1996, 32, 341–348. [Google Scholar] [CrossRef]
  147. Day, R.M.; Boccaccini, A.R.; Shurey, S.; Roether, J.A.; Forbes, A.; Hench, L.L.; Gabe, S.M. Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds. BioMaterials 2004, 25, 5857–5866. [Google Scholar] [CrossRef] [PubMed]
  148. Keshaw, H.; Forbes, A.; Day, R.M. Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass. BioMaterials 2005, 26, 4171–4179. [Google Scholar]
  149. Roether, J.; Gough, J.; Boccaccini, A.R.; Hench, L.; Maquet, V.; Jérôme, R. Novel bioresorbable and bioactive composites based on bioactive glass and polylactide foams for bone tissue engineering. J. Mater. Sci. Mater. Med. 2002, 13, 1207–1214. [Google Scholar] [CrossRef] [PubMed]
  150. Zhao, J.; Han, W.; Chen, H.; Tu, M.; Huan, S.; Miao, G.; Zeng, R.; Wu, H.; Cha, Z.; Zhou, C. Fabrication and in vivo osteogenesis of biomimetic poly (propylene carbonate) scaffold with nanofibrous chitosan network in macropores for bone tissue engineering. J. Mater. Sci. Mater. Med. 2012, 23, 517–525. [Google Scholar] [CrossRef] [PubMed]
  151. Shirosaki, Y.; Tsuru, K.; Hayakawa, S.; Osaka, A.; Lopes, M.A.; Santos, J.D.; Fernandes, M.H. In vitro cytocompatibility of MG63 cells on chitosan-organosiloxane hybrid membranes. BioMaterials 2005, 26, 485–493. [Google Scholar] [CrossRef]
  152. Ramaswamy, Y.; Wu, C.; Van Hummel, A.; Combes, V.; Grau, G.; Zreiqat, H. The responses of osteoblasts, osteoclasts and endothelial cells to zirconium modified calcium-silicate-based ceramic. BioMaterials 2008, 29, 4392–4402. [Google Scholar] [CrossRef]
  153. Rhee, S.-H.; Hwang, M.-H.; Si, H.-J.; Choi, J.-Y. Biological activities of osteoblasts on poly (methyl methacrylate)/silica hybrid containing calcium salt. BioMaterials 2003, 24, 901–906. [Google Scholar] [CrossRef]
  154. Luo, H.; Ji, D.; Li, W.; Xiao, J.; Li, C.; Xiong, G.; Zhu, Y.; Wan, Y. Constructing a highly bioactive 3D nanofibrous bioglass scaffold via bacterial cellulose-templated sol-gel approach. Mater. Chem. Phys. 2016, 176, 1–5. [Google Scholar] [CrossRef]
  155. Luo, H.; Zhang, Y.; Li, G.; Tu, J.; Yang, Z.; Xiong, G.; Wang, Z.; Huang, Y.; Wan, Y. Sacrificial template method for the synthesis of three-dimensional nanofibrous 58S bioglass scaffold and its in vitro bioactivity and cell responses. J. BioMater. Appl. 2017, 32, 265–275. [Google Scholar] [CrossRef]
  156. Wen, C.; Hong, Y.; Wu, J.; Luo, L.; Qiu, Y.; Ye, J. The facile synthesis and bioactivity of a 3D nanofibrous bioglass scaffold using an amino-modified bacterial cellulose template. RSC Adv. 2018, 8, 14561–14569. [Google Scholar] [CrossRef] [Green Version]
  157. Wu, C.; Ramaswamy, Y.; Kwik, D.; Zreiqat, H. The effect of strontium incorporation into CaSiO3 ceramics on their physical and biological properties. BioMaterials 2007, 28, 3171–3181. [Google Scholar] [CrossRef] [PubMed]
  158. Gandolfi, M.; Spagnuolo, G.; Siboni, F.; Procino, A.; Rivieccio, V.; Pelliccioni, G.; Prati, C.; Rengo, S. Calcium silicate/calcium phosphate biphasic cements for vital pulp therapy: Chemical-physical properties and human pulp cells response. Clin. Oral Inv. 2015, 19, 2075–2089. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  159. Mazón, P.; Piedad, N. Porous scaffold prepared from α′ L-Dicalcium silicate doped with phosphorus for bone grafts. Ceram. Int. 2018, 44, 537–545. [Google Scholar] [CrossRef]
  160. Lin, K.; Xia, L.; Li, H.; Jiang, X.; Pan, H.; Xu, Y.; Lu, W.W.; Zhang, Z.; Chang, J. Enhanced osteoporotic bone regeneration by strontium-substituted calcium silicate bioactive ceramics. BioMaterials 2013, 34, 10028–10042. [Google Scholar] [CrossRef] [PubMed]
  161. Liu, S.; Jin, F.; Lin, K.; Lu, J.; Sun, J.; Chang, J.; Dai, K.; Fan, C. The effect of calcium silicate on in vitro physiochemical properties and in vivo osteogenesis, degradability and bioactivity of porous β-tricalcium phosphate bioceramics. Biomed. Mater. 2013, 8, 025008. [Google Scholar] [CrossRef]
  162. Wang, C.; Lin, K.; Chang, J.; Sun, J. The stimulation of osteogenic differentiation of mesenchymal stem cells and vascular endothelial growth factor secretion of endothelial cells by β-CaSiO3/β-Ca3 (PO4) 2 scaffolds. J. Biomed. Mater. Res. Part A 2014, 102, 2096–2104. [Google Scholar] [CrossRef]
  163. Xiong, K.; Zhang, J.; Shi, H.; Liu, J.; Wu, H.; Li, H.; Ye, J. Preparation and in vitro cell-biological performance of sodium alginate/nano-zinc silicate co-modified calcium silicate bioceramics. RSC Adv. 2015, 5, 8329–8339. [Google Scholar] [CrossRef]
  164. Lin, K.; Lin, C.; Zeng, Y. High mechanical strength bioactive wollastonite bioceramics sintered from nanofibers. RSC Adv. 2016, 6, 13867–13872. [Google Scholar] [CrossRef]
  165. Lin, K.; Chang, J.; Lu, J.; Wu, W.; Zeng, Y. Properties of β-Ca3 (PO4) 2 bioceramics prepared using nano-size powders. Ceramics Int. 2007, 33, 979–985. [Google Scholar] [CrossRef]
  166. Kokubo, T.; Takadama, H. How useful is SBF in predicting in vivo bone bioactivity? BioMaterials 2006, 27, 2907–2915. [Google Scholar] [CrossRef] [PubMed]
  167. Turdean-Ionescu, C.; Stevensson, B.; Grins, J.; Izquierdo-Barba, I.; Garcia, A.; Arcos, D.; Vallet-Regí, M.; Edén, M. Composition-dependent in vitro apatite formation at mesoporous bioactive glass-surfaces quantified by solid-state NMR and powder XRD. RSC Adv. 2015, 5, 86061–86071. [Google Scholar] [CrossRef] [Green Version]
  168. Liu, S.; Gong, W.; Dong, Y.; Hu, Q.; Chen, X.; Gao, X. The effect of submicron bioactive glass particles on in vitro osteogenesis. Rsc Adv. 2015, 5, 38830–38836. [Google Scholar] [CrossRef]
  169. Lin, K.; Zhang, M.; Zhai, W.; Qu, H.; Chang, J. Fabrication and characterization of hydroxyapatite/wollastonite composite bioceramics with controllable properties for hard tissue repair. J. Am. Ceram. Soc. 2011, 94, 99–105. [Google Scholar] [CrossRef]
  170. Du, Z.; Guo, L.; Zheng, T.; Cai, Q.; Yang, X. Formation of core-shell structured calcium silicate fiber via sol-gel electrospinning and controlled calcination. Ceram. Int. 2019, 45, 23975–23983. [Google Scholar] [CrossRef]
  171. Geng, M.; Zhang, Q.; Gu, J.; Yang, J.; Du, H.; Jia, Y.; Zhou, X.; He, C. Construction of a nanofiber network within 3D printed scaffolds for vascularized bone regeneration. BioMater. Sci. 2021, 9, 2631–2646. [Google Scholar] [CrossRef]
  172. Kołbuk, D.; Heljak, M.; Choińska, E.; Urbanek, O. Novel 3D hybrid nanofiber scaffolds for bone regeneration. Polymers 2020, 12, 544. [Google Scholar] [CrossRef] [Green Version]
  173. Xiao, L.; Wu, M.; Yan, F.; Xie, Y.; Liu, Z.; Huang, H.; Yang, Z.; Yao, S.; Cai, L. A radial 3D polycaprolactone nanofiber scaffold modified by biomineralization and silk fibroin coating promote bone regeneration in vivo. Int. J. Biol. Macromol. 2021, 172, 19–29. [Google Scholar] [CrossRef]
  174. Pedrosa, M.C.G.; dos Anjos, S.A.; Mavropoulos, E.; Bernardo, P.L.; Granjeiro, J.M.; Rossi, A.M.; Dias, M.L. Structure and biological compatibility of polycaprolactone/zinc-hydroxyapatite electrospun nanofibers for tissue regeneration. J. Bioact. Comp. Polym. 2021, 36, 314–333. [Google Scholar] [CrossRef]
  175. Fraczek-Szczypta, A.; Rabiej, S.; Szparaga, G.; Pabjanczyk-Wlazlo, E.; Krol, P.; Brzezinska, M.; Blazewicz, S.; Bogun, M. The structure and properties of the carbon non-wovens modified with bioactive nanoceramics for medical applications. Mater. Sci. Eng. C 2015, 51, 336–345. [Google Scholar] [CrossRef]
  176. Rajzer, I.; Menaszek, E.; Bacakova, L.; Rom, M.; Blazewicz, M. In vitro and in vivo studies on biocompatibility of carbon fibres. J. Mater. Sci. Mater. Med. 2010, 21, 2611–2622. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  177. De Oliveira, A.A.R.; De Souza, D.A.; Dias, L.L.S.; De Carvalho, S.M.; Mansur, H.S.; de Magalhães Pereira, M. Synthesis, characterization and cytocompatibility of spherical bioactive glass nanoparticles for potential hard tissue engineering applications. Biomed. Mater. 2013, 8, 025011. [Google Scholar] [CrossRef] [PubMed]
  178. Yang, J.; Long, T.; He, N.-F.; Guo, Y.-P.; Zhu, Z.-A.; Ke, Q.-F. Fabrication of a chitosan/bioglass three-dimensional porous scaffold for bone tissue engineering applications. J. Mater. Chem. B 2014, 2, 6611–6618. [Google Scholar] [CrossRef] [PubMed]
  179. Smolka, W.; Dlugon, E.; Jelen, P.; Niemiec, W.; Panek, A.; Paluszkiewicz, C.; Zagrajczuk, B.; Menaszek, E.; Markowski, J.; Blazewicz, M. Carbon nanofibers coated with silicon/calcium-based compounds for medical application. J. NanoMater. 2019, 2019, 7172641. [Google Scholar] [CrossRef]
  180. Waisi, B.I.; Al-Jubouri, S.M.; McCutcheon, J.R. Fabrication and characterizations of silica nanoparticle embedded carbon nanofibers. Ind. Eng. Chem. Res. 2019, 58, 4462–4467. [Google Scholar] [CrossRef]
  181. Nekounam, H.; Kandi, M.R.; Shaterabadi, D.; Samadian, H.; Mahmoodi, N.; Hasanzadeh, E.; Faridi-Majidi, R. Silica nanoparticles-incorporated carbon nanofibers as bioactive biomaterial for bone tissue engineering. Diam. Rel. Mater. 2021, 115, 108320. [Google Scholar] [CrossRef]
  182. Nekounam, H.; Allahyari, Z.; Gholizadeh, S.; Mirzaei, E.; Shokrgozar, M.A.; Faridi-Majidi, R. Simple and robust fabrication and characterization of conductive carbonized nanofibers loaded with gold nanoparticles for bone tissue engineering applications. Mater. Sci. Eng. C 2020, 117, 111226. [Google Scholar] [CrossRef]
  183. Thompson, K.H.; Orvig, C. Boon and bane of metal ions in medicine. Science 2003, 300, 936–939. [Google Scholar] [CrossRef]
  184. Esteban-Tejeda, L.; Malpartida, F.; Esteban-Cubillo, A.; Pecharromán, C.; Moya, J. Antibacterial and antifungal activity of a soda-lime glass containing copper nanoparticles. Nanotechnology 2009, 20, 505701. [Google Scholar] [CrossRef]
  185. Lang, C.; Murgia, C.; Leong, M.; Tan, L.-W.; Perozzi, G.; Knight, D.; Ruffin, R.; Zalewski, P. Anti-inflammatory effects of zinc and alterations in zinc transporter mRNA in mouse models of allergic inflammation. Am. J. Phys. Lung Cell. Mol. Phys. 2007, 292, L577–L584. [Google Scholar] [CrossRef] [Green Version]
  186. Hoppe, A.; Mouriño, V.; Boccaccini, A.R. Therapeutic inorganic ions in bioactive glasses to enhance bone formation and beyond. BioMater. Sci. 2013, 1, 254–256. [Google Scholar] [CrossRef] [PubMed]
  187. Vallet-Regí, M.; Arcos, D. Silicon substituted hydroxyapatites. A method to upgrade calcium phosphate based implants. J. Mater. Chem. 2005, 15, 1509–1516. [Google Scholar] [CrossRef]
  188. Gentleman, E.; Fredholm, Y.C.; Jell, G.; Lotfibakhshaiesh, N.; O’Donnell, M.D.; Hill, R.G.; Stevens, M.M. The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro. BioMaterials 2010, 31, 3949–3956. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  189. Ahmed, I.; Parsons, A.; Jones, A.; Walker, G.; Scotchford, C.; Rudd, C. Cytocompatibility and effect of increasing MgO content in a range of quaternary invert phosphate-based glasses. J. BioMater. Appl. 2010, 24, 555–575. [Google Scholar] [CrossRef] [PubMed]
  190. Su, Y.; Cockerill, I.; Wang, Y.; Qin, Y.-X.; Chang, L.; Zheng, Y.; Zhu, D. Zinc-based biomaterials for regeneration and therapy. Trends Biotechnol. 2019, 37, 428–441. [Google Scholar] [CrossRef]
  191. Deliormanlı, A.M. Electrospun cerium and gallium-containing silicate based 13-93 bioactive glass fibers for biomedical applications. Ceram. Int. 2016, 42, 897–906. [Google Scholar] [CrossRef]
  192. Chen, L.; Pan, H.; Zhuang, C.; Peng, M.; Zhang, L. Joint wound healing using polymeric dressing of chitosan/strontium-doped titanium dioxide with high antibacterial activity. Mater. Lett. 2020, 268, 127555. [Google Scholar] [CrossRef]
  193. Sen, C.K.; Khanna, S.; Venojarvi, M.; Trikha, P.; Ellison, E.C.; Hunt, T.K.; Roy, S. Copper-induced vascular endothelial growth factor expression and wound healing. Am. J. Phys. Heart Circ. Phys. 2002, 282, H1821–H1827. [Google Scholar] [CrossRef] [Green Version]
  194. Frangoulis, M.; Georgiou, P.; Chrisostomidis, C.; Perrea, D.; Dontas, I.; Kavantzas, N.; Kostakis, A.; Papadopoulos, O. Rat epigastric flap survival and VEGF expression after local copper application. Plast. Reconst. Surg. 2007, 119, 837–843. [Google Scholar] [CrossRef]
  195. Tsai, S.-W.; Yu, W.-X.; Hwang, P.-A.; Huang, S.-S.; Lin, H.-M.; Hsu, Y.-W.; Hsu, F.-Y. Fabrication and characterization of strontium-substituted hydroxyapatite-CaO-CaCO3 nanofibers with a mesoporous structure as drug delivery carriers. Pharmaceutics 2018, 10, 179. [Google Scholar] [CrossRef] [Green Version]
  196. Zaichick, V.; Zaichick, S.; Karandashev, V.; Nosenko, S. The effect of age and gender on Al, B, Ba, Ca, Cu, Fe, K, Li, Mg, Mn, Na, P, S, Sr, V, and Zn contents in rib bone of healthy humans. Biol. Trace Elem. Res. 2009, 129, 107–115. [Google Scholar] [CrossRef] [PubMed]
  197. Zheng, T.; Zhao, H.; Huang, Y.; Gao, C.; Zhang, X.; Cai, Q.; Yang, X. Piezoelectric calcium/manganese-doped barium titanate nanofibers with improved osteogenic activity. Ceram. Int. 2021, 47, 28778–28789. [Google Scholar] [CrossRef]
Figure 1. Possible applications of ceramic nanofibers.
Figure 1. Possible applications of ceramic nanofibers.
Materials 15 03909 g001
Figure 2. Main studies addressing ceramic nanofibers applied in wound-healing applications over the last six years [20,66,67,68,69,70,71].
Figure 2. Main studies addressing ceramic nanofibers applied in wound-healing applications over the last six years [20,66,67,68,69,70,71].
Materials 15 03909 g002
Figure 3. Evolution of the implant area in Wistar rats: (A) control rat prior to surgical intervention; (B) two weeks after material implantation, being observed inflammation in the incisions on the subcutaneous tissue; (C) four weeks of the surgical intervention, with a significant decrease in inflammation; and (D) six weeks after the intervention, the rat showed a very noticeable surgical decrease in the incisions’ inflammation, with a considerable growth in the rat’s hair and its scars (reprinted from Garibay-Alvarado et al. [74], copyright (2021), with permission from PloS ONE).
Figure 3. Evolution of the implant area in Wistar rats: (A) control rat prior to surgical intervention; (B) two weeks after material implantation, being observed inflammation in the incisions on the subcutaneous tissue; (C) four weeks of the surgical intervention, with a significant decrease in inflammation; and (D) six weeks after the intervention, the rat showed a very noticeable surgical decrease in the incisions’ inflammation, with a considerable growth in the rat’s hair and its scars (reprinted from Garibay-Alvarado et al. [74], copyright (2021), with permission from PloS ONE).
Materials 15 03909 g003
Figure 4. Schematic representation of the influence of ceramic nanofibers on the wound healing process.
Figure 4. Schematic representation of the influence of ceramic nanofibers on the wound healing process.
Materials 15 03909 g004
Figure 5. Optical images of an in vitro wound-healing assay undertaken on a human skin fibroblast cell line: (A) SV 40-transformed GM 00637; (B) scratch created by micropipette on the confluent cell culture plate; (CE) control sample at 4, 6, and 24 h, respectively; (FH) ABGnf (without boron) at 4, 6, and 24 h; and (IK) ABGnf (with boron) at 4, 6, and 24 h, respectively. Reprinted from [88], copyright (2020), with permission from the International Journal of Applied Glass Science.
Figure 5. Optical images of an in vitro wound-healing assay undertaken on a human skin fibroblast cell line: (A) SV 40-transformed GM 00637; (B) scratch created by micropipette on the confluent cell culture plate; (CE) control sample at 4, 6, and 24 h, respectively; (FH) ABGnf (without boron) at 4, 6, and 24 h; and (IK) ABGnf (with boron) at 4, 6, and 24 h, respectively. Reprinted from [88], copyright (2020), with permission from the International Journal of Applied Glass Science.
Materials 15 03909 g005
Figure 6. Main studies addressing ceramic nanofibers applied in bone regeneration applications over the last six years [23,55,56,74,114,115,116,117,118,119,120,121].
Figure 6. Main studies addressing ceramic nanofibers applied in bone regeneration applications over the last six years [23,55,56,74,114,115,116,117,118,119,120,121].
Materials 15 03909 g006
Figure 7. Live/dead immunofluorescence staining results of osteoblast cells cultured for one (A,D), three (B,E), and five (C,F) days on binary glass nanofibrous scaffold (AC), as well as a blank control (DF). Reprinted from Luo et al. [55], copyright (2017), with permission from Materials Science and Engineering: C.
Figure 7. Live/dead immunofluorescence staining results of osteoblast cells cultured for one (A,D), three (B,E), and five (C,F) days on binary glass nanofibrous scaffold (AC), as well as a blank control (DF). Reprinted from Luo et al. [55], copyright (2017), with permission from Materials Science and Engineering: C.
Materials 15 03909 g007
Figure 8. SEM images and the corresponding high magnification images of NBG scaffolds (A), after immersion in SBF for (B,C) one, (D,E) three, and (F,G) seven days (insets show local enlarged areas). Reprinted from [156], copyright (2018), with permission from RSC Advances.
Figure 8. SEM images and the corresponding high magnification images of NBG scaffolds (A), after immersion in SBF for (B,C) one, (D,E) three, and (F,G) seven days (insets show local enlarged areas). Reprinted from [156], copyright (2018), with permission from RSC Advances.
Materials 15 03909 g008
Figure 9. (A) MTT activity of MC3T3-E1 cells cultured on studied scaffolds for 7, 14, and 21 days. (B) Total protein content (μg/mL), up to 7, 14, and 21 days of cell culture of the osteoblastic lineage MC3T3 cultured on the studied scaffolds. (C) Alkaline phosphatase activity (U/L) of MC3T3-E1 cells on the studied scaffolds. (* statistical significant differences with p-value < 0.05; ** statistical significant differences with p-value < 0.01; *** statistical significant differences with p-value < 0.001). Reprinted from [23], copyright (2021), with permission from Ceramics International.
Figure 9. (A) MTT activity of MC3T3-E1 cells cultured on studied scaffolds for 7, 14, and 21 days. (B) Total protein content (μg/mL), up to 7, 14, and 21 days of cell culture of the osteoblastic lineage MC3T3 cultured on the studied scaffolds. (C) Alkaline phosphatase activity (U/L) of MC3T3-E1 cells on the studied scaffolds. (* statistical significant differences with p-value < 0.05; ** statistical significant differences with p-value < 0.01; *** statistical significant differences with p-value < 0.001). Reprinted from [23], copyright (2021), with permission from Ceramics International.
Materials 15 03909 g009
Figure 10. (A) Weight loss, cumulative release of (B) calcium ions and (C) silicate ions from sintered nanofibers of CS-800, CS-1000, and CS-1200; (D1D3) shows SEM images and (E1,E3) TEM images of the corresponding calcium silicate nanofibers, after degradation in deionized water at 37 °C for 21 days; (D1,E1) corresponding to CS-800 composition; (D2,E2) corresponding to CS-1000 and (D3,E3) to CS-1200. Reprinted from [170], copyright (2019), with permission from Ceramics International.
Figure 10. (A) Weight loss, cumulative release of (B) calcium ions and (C) silicate ions from sintered nanofibers of CS-800, CS-1000, and CS-1200; (D1D3) shows SEM images and (E1,E3) TEM images of the corresponding calcium silicate nanofibers, after degradation in deionized water at 37 °C for 21 days; (D1,E1) corresponding to CS-800 composition; (D2,E2) corresponding to CS-1000 and (D3,E3) to CS-1200. Reprinted from [170], copyright (2019), with permission from Ceramics International.
Materials 15 03909 g010
Figure 11. Schematic representation of the influence of ceramic nanofibers on the wound-healing process.
Figure 11. Schematic representation of the influence of ceramic nanofibers on the wound-healing process.
Materials 15 03909 g011
Figure 12. Evaluation of osteogenic differentiation of BMSCs cultured on doped and non-ion doped nanofibers compositions by an analysis of osteogenesis-related markers including: (A) quantitative analysis on ALP activity; (B) quantitative analysis on COL-I synthesis; (C) ALP staining and Alizarin red staining for calcium modules. * p < 0.05, significant; ** p < 0.01 and *** p < 0.001, highly significant (n = 4). Reprinted from [197], copyright (2021), with permission from Ceramics International.
Figure 12. Evaluation of osteogenic differentiation of BMSCs cultured on doped and non-ion doped nanofibers compositions by an analysis of osteogenesis-related markers including: (A) quantitative analysis on ALP activity; (B) quantitative analysis on COL-I synthesis; (C) ALP staining and Alizarin red staining for calcium modules. * p < 0.05, significant; ** p < 0.01 and *** p < 0.001, highly significant (n = 4). Reprinted from [197], copyright (2021), with permission from Ceramics International.
Materials 15 03909 g012
Table 1. Summary information about ceramic nanofibers for wound healing application.
Table 1. Summary information about ceramic nanofibers for wound healing application.
NanofiberMethodComposition (mol)Physical–Chemical PropertiesDiameter (nm)Biological PropertiesReference
Silica hybridsElectrospinningSílica (SiO2)
Sílica (SiO2)–Bioactive glass (58% SiO2, 38% CaO, 4% P2O5)
Withstand autoclave sterilization
Porosity: 93.2%
107–500Non-cytotoxic, biocompatible, it facilitates the homogeneous growth of floclayer-type carbonated hydroxyapatite within a short period of immersion. Rapid cell growth with specific functions of hepatocytes per volume of substrates. They promote an increase in the hydrophilicity of the material, improving cell adhesion.[20,66]
Hydroxyapatite hybridsElectrospinningHydroxyapatite (Ca10(PO4)6(OH)2)–Silica (SiO2)Surface area: 6.57 m2/g
Pore volume: 0.025 cm3/g
110 Non-cytotoxic, biocompatible, bioactive, they have a high percentage of viability in a fibroblast lineage, stimulate cell growth, serve as cell support and allow cells to anchor. They promote the reduction in incision inflammation in vivo test after six weeks of surgical intervention.[74]
Silver-containing nanofiberElectrospinningSilica (SiO2)-Silver (0.05, 0.1 and 0.15 Ag)
Silver- Bioactive glass (2% B2O3, 68–69% SiO2, ~1 × 10−3 Ag2O, 29–30% CaO)
Properties not informed200–390They inhibit the proliferation of Escherichia coli with a long-term antibacterial effect, providing antibacterial potential to the wound bed. Non-cytotoxic, promoting cell growth over a wide concentration range. They allow the loading of drugs such as Tetracycline (TC) and have the ability to delay the release of TC and maintain antibacterial activity, inhibiting bacterial growth for a period of seven days.[67,72,88]
Calcium-containing nanofiberElectrospinning Silica (100-X% SiO2)–Calcium (X% CaO), with X: 0, 20, 30, 40Surface area: 40–43.1 m2/g210–340Increases the production of human vascular endothelial growth factor (VEGF) in a human dermal fibroblast cell line (CD-18CO) and promotes improved wound healing when compared to control.[68]
Boron-containing nanofiber Electrospinning Bioactive glass–Boron (2% B2O3, 68–69% SiO2, 29–30% CaO)Properties not informed 200–900 Higher wound healing rates after 24 h of testing. The presence of boron promoted healing of 82% and increased cell proliferation.[88]
Cobalt-containing nanofiber Electrospinning Bioactive glass–Cobalt (50% SiO2, 24% Na2O, 24% MgO, 2% CoO)The ability to act as both a network modifier and a network former 1000 They provided more sustained ion release compared to bioactive glass particles alone. Exposure of fibroblasts to the conditioned medium of these composites did not have a deleterious effect on metabolic activity, but the cobalt-containing glasses stabilized HIF-1α and caused significantly increased expression of VEGF (not observed in controls without Co).[69]
Copper-containing nanofiberElectrospinningBorate bioactive glass- copper
(6% Na2O, 8% K2O, 8% MgO, 22% CaO, 54% B2O3, 2% P2O5, 3% CuO)
Thermal stability0.4–1.2 μmPromising ability to stimulate angiogenesis and heal full-thickness skin defects.[96]
Table 2. Summary information about ceramic nanofibers for application in bone tissue regeneration.
Table 2. Summary information about ceramic nanofibers for application in bone tissue regeneration.
NanofiberMethodComposition (mol)Physicochemical PropertiesDiameter (nm)Biological PropertiesReference
Calcium PhosphateElectrospinning, Solution Blow SpinningHydroxyapatite (Ca10(PO4)6(OH)2)
β-Tricalcium phosphate
(Ca₃(PO₄)₂)
Hydroxyapatite (Ca10(PO4)6(OH)2)-Silica (SiO2)
Hydroxyapatite (Ca10(PO4)6(OH)2)–CaO
Hydroxyapatite-Calcium (66.3% Ca10(PO4)6(OH)2), 21.1% CaO, 12.6% CaCO3)
Low strength and fracture toughness
Surface area: 6.57–8 m2/g
Pore volume: 0.025 cm3/g
Pore size: 15.75–25 nm
100–460High bioactivity, non-cytotoxic, and good biocompatibility, in addition to having good drug control release properties.[31,56,74,89,122,195]
Bioactive glassElectrospinning, Solution Blow Spinning, Template-Assisted Sol–GelBinary glass (60% Si, 40% Ca)Surface area: 144.60–579 m2/g
Porosity: 63.8%
Pore size: 3.5–45 nm
Pore volume: 0.21 cm3 g−1
16–358Excellent biocompatibility, high bioactivity in SBF, high ALP activity, good degradation rate, promotes cell adhesion, and accelerates osteoblast proliferation and differentiation.[32,55,154,156]
WollastoniteElectrospinning, Hydrothermal Synthesisβ-wollastonite (β-CaSiO3)
Wollastonite (CaSiO3)–Silica (SiO4)–Zinc (10% Zn)
High bending strength of 145.70 ± 2.74 MPa
Porosity: 9.5–22.8%
10–500Excellent bioactivity, good osteogenic differentiation of mesenchymal stromal cells, ability to release bioactive, and slowly degradable ions in inducing bone regeneration.[128,164,170]
Hybridized carbonElectrospinning, electrospinning/electrosprayingCarbon-Bioactive glass (89.65% C, 7.61% O, 2.28% Si, 0.10% P, 0.35% Ca)
Carbon-Silica (5–10% SiO2)
Carbon–Gold (1–2.5–5% Au)
Carbon-Hydroxyapatite (34% C, 23% O, 11% P 32% Ca)
Higher dissolution rate
High surface area and flexibility
Porosity: 76%
190–320Rapid cell proliferation and differentiation (indicating a strong osteoactive behavior), high ALP expression, biocompatible, and low level of cytotoxicity.[54,117,179,181,182]
Therapeutic ions-containing nanofiber (Ce, Ga, Sr, Cu, Ca and Mn)ElectrospinningHydroxyapatite–Calcium (96.1% Ca10(PO4)6(OH)2), 1.4% CaO, 2.5% CaCO3)–Strontium (30% Sr)
Bioactive glass (53% SiO2, 6% Na2O, 12% K2O, 5% MgO, 20% CaO e 4% P2O5) -Cerium-gallium (1–5% Ce and Ga)
Barium titanate (BaTiO3)–Calcium-Manganese (10% Ca, 2% Mn)
Piezoelectricity, ion release and degradation behaviors.
Pore size: 20–25 nm
103–582Good biocompatibility, showed no cytotoxicity, improving bioactivity by promoting the activity of osteoblastic and endothelial cells, and inhibiting the formation of osteoclasts or bone resorption cells.[119,191,195,197]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

dos Santos Gomes, D.; de Sousa Victor, R.; de Sousa, B.V.; de Araújo Neves, G.; de Lima Santana, L.N.; Menezes, R.R. Ceramic Nanofiber Materials for Wound Healing and Bone Regeneration: A Brief Review. Materials 2022, 15, 3909. https://doi.org/10.3390/ma15113909

AMA Style

dos Santos Gomes D, de Sousa Victor R, de Sousa BV, de Araújo Neves G, de Lima Santana LN, Menezes RR. Ceramic Nanofiber Materials for Wound Healing and Bone Regeneration: A Brief Review. Materials. 2022; 15(11):3909. https://doi.org/10.3390/ma15113909

Chicago/Turabian Style

dos Santos Gomes, Déborah, Rayssa de Sousa Victor, Bianca Viana de Sousa, Gelmires de Araújo Neves, Lisiane Navarro de Lima Santana, and Romualdo Rodrigues Menezes. 2022. "Ceramic Nanofiber Materials for Wound Healing and Bone Regeneration: A Brief Review" Materials 15, no. 11: 3909. https://doi.org/10.3390/ma15113909

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop